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Oak Ridge National Laboratory 
P. 0. Box X 
Oak Ridge, TN 37831 
Monthly Progress Letter - Our Project E25-M36  
Dear Dr. Bogard: 
Owing to the late contractual start of the dosimetry project, there is 
not much to report at this stage. I spent a useful day at ORNL on March 7, 
1988 discussing the project with Keith Eckerman, Mint Thein and yourself. 
As a result the project procedure was clarified and a series of nuclides 
was identified for priority in evaluation. 
We have worked out our own approach in the meantime with primary 
reliance on ICRP 10 and 30 and the Lessard BNL report. I still look 
forward to receiving a copy of the Dunning report from you. 
Please call me if you have any questions, at 404-894-3722. 
Yours sincerely, 
G. G. Eichholz 
Regents' Professor 
GGE/jr 
P.S. We just received the contract on the TLD project and are launching 
right into it. 
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Dr. James S. Bogard 
Environmental and Occupational Safety Div. 
Oak Ridge National Laboratory 
P. O. Box X 
Oak Ridge, TN 37831 
Monthly Progress Report - Our Project E25-M36  
Dear Dr. Bogard: 
During the month considerable progress has been made to develop a 
reasonable technical approach to the problem and to gain experience in 
utilizing the data bases in ICRP 10 and 30, the Lessard BNL report and the 
Dunning report. Applying both the exponential and the power series models 
to the case of cesium-137, reasonable agreement between the models was 
obtained, but it also became clear that their use during the first 24 hours 
after inhalation is subject to some limitations. There is also a 
discrepancy arising from the different mean particle sizes assumed in the 
various reports and we are trying to reconcile these calculations, adopting 
an AMAD of one micron as the "standard" size. 
Work is under way on uranium and a method has been developed, based on 
the BNL data, to estimate lung retention and to calculate dose. We have 
spent some time defining the nature of our input data (measured excretion, 
leading to an inhalation estimate) and the required output in terms of lung 
dose, fraction of ALI and 50-year dose commitment. 
It is planned for Mr. T. K. Haider to visit your group on April 22, 
1988 for discussion. That will help him gain more of a perspective on the 
problem and, in discussion with you and Dr. Eckerman, may resolve some 
questions on alternative model approaches that may have arisen. 
We are proposing to submit an abstract on this work to Dr. Swaja for 
the Orlando meeting in October 1988. At this stage, the abstract has to be 
worded rather vaguely and you might explain to him that we expect to have 
some solid results by the end of summer. 
Please call me if you have any questions. 
Yours-truly, 
G. G. Eichhol 
Regents' Profs 
GGEk 
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P.O. Box X 
Oak Ridge, Tennessee 37831 
Monthly Progress Report - Our Project E25-M36 
Dear Dr. Bogard: 
During the past month work has been concentrated on uranium dose estimation using 
the data base in ICRP10 and 30 and the Lessard BNL report. A literature search has 
been done on sources of uranium dust, solubility of uranium oxides in vitro and in vivo, 
the feasibility of determining lung dose from excretion rates, and regulatory guidelines. 
A draft outline of this review is attached as requested. In addition, we are looking at 
the available data bases for plutonium and neptunium, with particular reference to 
ICRP48. 
Mr. T. K. Haider, the graduate student doing much of the work, visited ORNL on April 
22 and gave an impromptu presentation of the present status and had discussions with 
several members of your group. 
An abstract on the general approach to this problem has been submitted for the 
Orlando meeting in October, 1988. 
Please call me at 404-894-3722 if you have any questions. 
Yours truly, 
• 
G. G. Eichholz 
Regents' Profes 
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Monthly Progress Report - Our Project E25-M36 
Dear Dr. Bogard: 
Since our last report, dose calculations have been performed for plutonium inhalation. 
ICRP 30 and 79 models have been compared and its concluded that the ICRP 79 
model, which is concerned with chronic exposure and does not consider excretion 
explicitly, is not really relevant to our concerns. 
The ICRP 30 model seems to give a good estimate of intake from excretion fractions 
when corrected for particle size and elapsed time since the bolus intake(s). 
Chi square statistics are used in estimating intake and the procedures for working back 
from excretion data are not greatly different for different models. A complete method 
for Pu, sample calculations and excretion data may be expected in early July. 
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Monthly Progress Report - Our Project E25-M36 
Dear Dr. Bogard, 
During the past months, calculations have been done for U and Pu intake 
values as a function of particle size. Reasonably good agreement has been 
obtained with reported measurements on excretion following UF6 inhalation. 
Uncertainties are relatively high and we are trying to quantify them. 
Work is also under way to tabulate relationships between excretion values, 
at various times after intake, with calculated lung dose and fractional 
ALI, which I consider the primary objective of this project. 
We would welcome an opportunity to discuss this work, if you are still 
planning a visit here. 
Yours sincerely, 
cc: P. Heitmuller (OCA) 
R. F. Dawkins (ME) 
Telephone: 404-894-3720 	Telex: 542507 GTRIOCAATL 	Fax: 404-894-3120 (Verify: 404-1394-6951) 
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Monthly Progress Report - Our Project E25-M36 
Dear Dr. Bogard, 
During the month relationships between excretion, intake, lung dose and ALI 
have been recalculated and tabulated for U-238 and Pu-239 particulates and it 
is planned to extend this procedure to other nuclides. 
We expect to discuss progress on this project and the logical next stages with 
you and your colleagues during a visit to ORNL planned for Friday, August 
19, 1988 and hope to discuss various aspects of this work in more detail then. 
Yours sincerely, 
GGE/lg 
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Dear Dr. Bogard, 
Since our last report, the dose calculations have been on a routine program 
with a standard format and data have now been tabulated for the actinides 
of interest. 
Mr. Haider and I visited your group on August 19 and as a result the list 
of radionuclides to be covered has been updated. 
We have requested a slight extension of the contract period to permit us to 
complete these calculations. 
Sincerely, 
Geoffrey G. Eichho 
Regents Professor 
GGE/lg 
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Monthly Progress Report - Our Project E25-M36 
Dear Dr. Bogard: 
During the past month the bulk of the proposed dose calculations have been 
done and data have been tabulated for U, Pu, Am, Sr, Ce and Cs, with Co 
being worked on at the moment. The remaining nuclides, H-3 and C-14 are 
less well documented and may require a different approach for different 
airborne compounds. Consequently, I am not sure that we will be able to 
complete work on those two within the term of the present contract. 
I hope to put together the methodology and results of the present work by 
the middle of next month and will send you the draft report for your review. 
In the meantime we will make a preliminary presentation of this work at the 
Orlando Dosimetry Conference in early November. 
Please give me a call at 404-894-3722 if there are any questions. 
Yours '*.incerely, 
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cc: P. Heitmuller (OCA 
R. F. Dawkins (ME) 
Telephone: 404 -894 -3720 	- x: 542507 GTRIOCAATL 	Fax: 404-894-3120 (Verify: 404-894-6951) 
AN EOUi 	 'ATION AND EMPLOYMENT OPPORTUNITY INSTITUTION 
Georgia Institute of Technology 
A UNIT OF THE UNIVERSITY SYSTEM OF GEORGIA 
NUCLEAR ENGINEERING AND HEALTH PHYSICS PROGRAMS 
SCHOOL OF MECHANICAL ENGINEERING 
October 14, 1988 
Please reply to: 
NUCLEAR ENGINEERING AND 
HEALTH PHYSICS PROGRAMS 
ENGINEERING SCIENCE AND 
MECHANICS BUILDING 
GEORGIA INST. OF TECHNOLOGY 
ATLANTA GEORGIA 30332 USA 
Dr. James S. Bogard 
Div. of Environmental Sc Health Protection 
Oak Ridge National Laboratories 
P.O. Box 2008 
Oak Ridge, Tennessee 37831 
Monthly Progress Report - Our Project E25-M42 
Dear Dr. Bogard: 
The project now has entered essentially a routine phase. Both types of TLD 
badges are being exposed, as planned, over a range of dose rates and total 
doses. Three batches have been sent to ORNL for reading and we have just 
received the first list of readings from Dr. Rhea. 
These activities will continue during the coming weeks. 
Yours sincerely, 
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Geoffrey G. Eichholi -
Regents' Professor 
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SUMMARY 
A practical problem in internal dosimetry may arise when an individual is 
accidentally exposed to airborne radioactive materials. Normal procedure would call 
for urine analysis to establish the presence of any body burden and to permit an 
assessment of the radiological consequences of this event. 
Current assessment procedures, based on ICRP 30 methodology, are largely 
directed to steady-state chronic exposures. This report presents data obtained on the 
basis of the ICRP 30 model for the lung doses resulting from singular inhalation events 
as deduced from measurements on excreta. Tables are presented for the fraction of the 
annual limit of intake (ALI) represented by unit activity in the excreta as a function of 
sampling time and the concomitant dose commitments. 
Data have been tabulated, for the various lung retention classes, for Co-60; Sr-
89, 90; 1-125, 131; Cs-134, 137; U-233, 234, 235, 238; Pu-238, 239 and Am-241, 242. 
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INTRODUCTION 
The accurate estimate of internal dose and implied dose commitment for a person, 
who has been occupationally or accidentally exposed to airborne activity, is an 
important aspect of the safe operation of any nuclear facility that has a potential for 
such exposures. In the past, such internal doses were calculated on the basis of the 
critical organ dose postulated in the procedure outlined in ICRP Report No. 2 (1), 
which simply divided source material according to whether it was soluble or insoluble. 
The redefinition of internal dose through a distinction between stochastic and non-
stochastic consequence chains and the use of an improved lung model were 
incorporated in the more recent recommendations published as ICRP Reports 26 (2) 
and 30 (3). The emphasis in the latter is on the relationship between intake and 
committed tissue dose-equivalent by means of a series of general transfer equations, 
that are interlinked and require a detailed knowledge of all relevant transfer 
coefficients. This is not, typically, a calculation that can be done at short notice. 
The present report deals with the situation where a worker may be exposed to 
unknown concentrations of airborne materials for a short time and a determination 
must be made of the effective dose equivalent received and the fraction of the annual 
limit of intake (ALI) the particular event represented. Although the particular 
radionuclides and their physical/chemical form will be known, in general, the only 
quantitative information available will be the activity excreted. Hence, the purpose of 
1 
the present work was to provide a direct link between the activity in excreta, essentially 
in urine, at specific sampling times after intake and the calculated lung dose. Figure 1 
illustrates the relationships involved, i.e. given a urinalysis assay, the presumed intake is 
estimated and from this the lung dose, fractional ALI committed and dose commitment 
are derived. 
Fortunately, it was not necessary to go back to first principles. Retention models 
have been published in ICRP 10(4) and ICRP 30 (3). A very substantial tabulation of 
organ deposition and excretion coefficients for most radionuclides of interest has been 
published by Lessard et al. (5) and Dunning (6) has tabulated organ doses from 
inhalation for particle sizes of 0.3, 1.0 and 5µm AMAD for environmentally significant 
radionuclides, as well as the 50-year dose commitment per microcurie intake. The 
present task then was to correlate this information and to present it in a readily usable 
form. The principal interest lay in the evaluation of actinide radionuclides, which have 
been considered in more detail, and of some of the major, non-gaseous, fission 
products. A typical discussion of uranium product inhalation was published recently by 
Kvasnicka (7); a parallel discussion of intake retention functions and the estimation of 
internal radiation doses by Skrable et al. (17) appeared while this report was in 
preparation. 
2 
50 year D 0 S E 
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(at specified time) 
Figure 1: Schematic Relationship Between Intake, Excretion and Dose 
3 
CHOICES OF A MODEL 
To obtain a satisfactory correlation between uptake, excretion and lung dose for 
inhaled particulates the choice of an appropriate model is important. This entails the 
construction of a compartmentalized structure with identifiable transfer paths between 
all organs of interest and between compartments within an organ, such as the lung, and 
the subsequent calculation of organ doses resulting from deposition in the critical 
organ; in the present case, this was the lung for most of the radionuclides considered. 
Most of the dose calculations are derived from refinements of the MIRD model (8), 
which led to calculations of absorbed fractions (of the dose) in various organs for a 
uniform deposition of active material in the lung. The relationship between deposition 
of inhaled material in the various regions of the lung, translocation into the blood 
stream and excretion through the kidneys is rather complex and depends on solubility, 
particle size, chemical form and partial diversion into the lymphatic system (9). The 
process of dissolution and translocation of actinide particles in lung fluids is difficult to 
analyze. Cooke and Holt (10) have attempted to simulate translocation in lung fluid for 
some uranium compounds and Ryan (11) for plutonium. 
Figure 2 shows the respiratory model adopted in ICRP 30 (3), with a table for the 
removal half-times from the lung and the compartmental fractions for removal paths for 
each of the compartments. In general, removal to the lymph system is significant only 
for the pulmonary parenchyma (P) region. The fraction deposited in each region on 
4 
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Figure 2: 	Mathematical model and clearance times for the respiratory system (3) 
Percent deposition 
Figure 3: 	Dust deposition in lung compartments for various particle sizes (3) 
5 
inhalation depends on particle size, as expressed by the activity median aerodynamic 
diameter (AMAD), as shown in Fig. 3 (3). The lung retention is a function of particle 
size and chemical solubility and is roughly categorized by the Classes D, W and Y, 
which are assigned largely on an empirical basis (e.g. 12). 
The lung model gives rise to a series of interlinked first-order differential 
equations describing the transport from one compartment, in Fig. 2, to another in terms 
of coefficients describing the inhalation rate, the biological clearance rates of each 
compartment, and the radioactive decay rates for the radionuclide. The various models 
proposed are similar in format, but differ in their completeness and in the 
approximations attempted. This is illustrated in Table 1, which compares several 
equations proposed in ICRP 10 (4) and 10A (draft) to describe the retention in man of 
strontium-90. Note that most equations are composed of exponential terms, but Case c 
includes a power term. Since the integrated retention determines the committed dose, 
it is obvious that the choice of equation (or model) is important. 
A similar situation exists for excretion models. Again several pathways have to be 
considered and Table 2 shows the fractional excretion equations proposed in ICRP 10 
(4). 
The following pages illustrate the consequences of choosing one or the other 
model for the case of strontium-90/89, to indicate the magnitude of the difference in 
estimated doses that may arise. 
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TABLE 1 
Proposed Retention Equations for 90Sr (4) 
ICRP 10 proposes several equations to describe retention in man. 
R(t) = 	fraction of intake retained in total body t days after the contamination event 
Q = 	time integral of internal contamination resulting from an uptake or 
deposition of 1 Ica expressed in ACi-days 
t = 	# of days after contamination 
a.  R (t) = 0.4 exp 	[- 0.693 t + 0.3 exp [- 0.693 t 
1.7 4.4 
[ 
+ 0.14 exp 	- 0.693 t + 0.15 
50 
[ 
b. R (t)= 0.73 exp - 0.693 t + 0.1 exp - 0.693  
3 	 44 
[ 
+ 0.17 exp - 0.693 t 
4000 
c. R (t) 	= 0.5 exp - 0.693 t + 0.5 t - 	 . 2 
2.4 
d. R (t) = 0.56 exp - 0.693 
[ 
t 	+ 0.24 exp - 0.693 t 
1.8 8 




Fractional Eicretion Equations (4) 
Y„ (t) = fraction excreted by single routes 
Y (t) = fraction excreted by all routes per day on the t th day after contamination 
event 
a. Y (t) = 0.73 [0.6931 exp [ - 0.693 t] + 0.1 [0.6931  
[ 
	
+ 0.17 0.693 exp 	-0.693 t 
4000 	4000 
b. Yu (t) = - 0.8 dR = 0.12 exp - 0.693 t + 0.08 t -1 . 2 
 dt 	 I 	2.4 
c. Yu (t) = - 0.67 dR = 0.14 exp 	-0.693 t + 
dt 	 1.8 
[ 
0.14 exp 0.693 t + 1.5 x 10 -4 exp - 0.693 t 
8 	 600 
3 	 3 44 
8 
COMPARISON OF MODELS - 90Sr CASE 
A. Dose calculation for a given uptake 
The first problem in estimating the 50-year radiation dose resulting from a single 
intake of strontium is to select a retention equation. Of the four equations, b and c 
were derived from a survey of literature and proposed for use in radiation protection 
work. Sample calculations of ORNL (13) used Equation b. Equation b is an 
exponential model and easily integrable. Equation g is a power function and an 
exponential function. 






3 + Tr t 	tdt 
     
T 	
1n2 	1n2 I 




+ f 0.17 exp ( - 1n2 
	1n2 	
tdt 
4000 Tr ) 
0 
where 	Tr = radioactive half-life in days. 
q. = initial uptake in ACi 
Q = internal deposition as defined in Table 1 
= qo Q for an uptake of q. 
go 
9 
For 90Sr 50 year dose - T112  = 10,000 days 
50 yr 
12 
Q = 0.73 	
J 
 0.73 exp I - 
31n2 - 10,n000 












+ f 0.10 exp ( - 
0 
50 yr 
+ j 0.17  exp ( 
0 
[ 	
1 	- 0.231 t 	 1 	- 0.01575t 
Q = (0.73) 
0.231 0.01575 
e 
0.17 	- 0.0002426t 
0.0002426 
t = 50 yr = 18,250 days 
Q = 3.16 + 6.349 + 700.74 (1 - 0.0119) = 3.16 + 6.349 + 692 
= 701.91 - 702 ACi-day. 
NOTE: ICRP 10 gives a value of 709 ACi-day. 
The discrepancy arises from two causes: 
1. They used bone as the critical organ and did not include the first term in 
equation b, because it does not describe the retention in bone. 
2. They ignored the upper limits The upper limit is zero for the first two 
terms and 0.0119 for the third term. 
10 
If the dose to the bone only is of interest, one obtains (first term ignored) 6.349 + 
692 = 698.349, as opposed to 709 MCi-day in ICRP 10. 
According to ICRP 10, use of the power function yields a value for Q of 980 jCi-
days. The difference between the two models then is: 
I 702 - 980  I x 100% = 39.6% 
702 
if 702 is taken to be the reference value; otherwise if 980 is taken to be the reference 
value, the percent different is 28.36%. Either way, there is a significant difference. 
ICRP 10 (4) has tabulated the values of Q using power functions and exponential 
functions also for 89Sr: 
Q using power function 	= 18.1 for Bone 
difference = 4.4% 
Q using exponential function 	= 18.9 for Bone 
It is noted that for short-half-life nuclides, both power function and exponential 
function give about the same value for Q. However, the power function gives a much 
larger value for Q in the case of long-lived radionuclides, such as 90Sr. 89Sr has a 50.6 
day half life. 
In order to be conservative, ICRP 10 uses the power function to calculate dose to 
the critical organ. 
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A. Dose Calculations 
Dose to the total body from an intake of 1 tiCi is given by (4) 
D= Q x 51.2 X m in rems 
where m is the mass of the organ or total body weight and 
EF (RBE) n (E in MeV) for the appropriate organ 
For Bone m = 7000 g 
c = 5.5, 
and we obtain 
D = 51.2 x 698.349 x 5.5 	= 28.10 rem 
7000 
ICRP CALCULATION 
D = 51.2 x 709 x 5.5 	= 28.522 rem 
7000 
Use of the power function turns out to be slightly more conservative. In that case 
the calculation gives 
D = 39.4 rem, for a difference in dose to the bone of 27.6%. 
It is obviously important to be consistent in using these models, but equally 
important not to overestimate dose merely for conservatism. 
Calculation of First-Year Dose To the Bone  
For 90Sr 
Exponential Model-: 
Q' (1 year) = q0 [3.16 + 6.35 (1 - 0.003) + 700 (1 - 0.915)] 
12 
integrating 0 - 1 year = 68.99 = 68.99 — 69 q o ACi-day 
The first year dose to the whole body 
= 69 qo x 0.04 rem/ACi-day = 2.76 q o rem 
Dose to bone (power function) 
1 year 
	
Q' = qo 0.5 
J 




t dt (gi - days) 
0 
Dose to bone (exponential model) 
Q' = qo [(6.35 (1 - 0.003) + 700 (1 - 0.915)] 
= 65.8 q0 gi-day 
Dose = 65.8 q 0 x 0.04 = 2.63 q0 rem 
63 
Proportional dose to bone = 
2.
x 100% = 95.3% of whole body dose 
2.76 
Since over 95% of the dose is to the bone, the dose to the whole body, using the 
power function, is not considered in detail. 
89Sr (exponential model) whole body 
365 x 50 
1n2 	1n2
J
t + exp ( 
	1n2 	1n2 I t 
Q = 0.73 j[exp ( 
j 3 51 	 44 51 
0 
+ exp 1n2 	1n2 I ti dt 
4000 51 j 
= 2.98 + 3.41 + 12.51 	= 18.90 gi-days 
For Q (1 yr) = 2.98 + 3.41 + 12.51 (1-0.0007) = 18.81 gi-days 
13 
For Bone only ignore first term (ICRP 10, p.56) 
Then Q = 15.92 jCi-days 
Q (1 yr) = 15.83 jCi-days 
and f (dose determination function) - Dose 
Q 
Dose Commitment 
Bone 050 = 51.2 x 15.92 x 2.8 
7000 
 - 0.326 - 0.33 rem 
 
28 
Whole Body 050 = 51.2 x 18.9 x 7000 - 0.387 - 0.39 rem 
39 
	
. 	 rem  
f (whole body) = 0 = 0.0206 
18.9 gCi-day 
Q (1 year) = 18.81 	gCi-day per microcurie intake 
Dose to 1st year = 18.81 x 0.0206 = 0.387 rem to whole body 
per gCi intake 
Dose to bone = 15.83 x 
0.33- 
 0.328 rem* 15.92 
First Quarter Bone Dose Per /Xi-Intake  
Q (90 day) = 2.98 + (1-0.071) 3.41 + 12.51 (1-0.2897) 
Whole Body = 2.98 + 3.168 + 8.885 
= 15.04 gCi-days 
Bone 	= 12.05 gCi-days 
Dose Dgo 	= 
0
.39 x 15.04 = 0.31 rem 
(Whole Body) 18.9 
0.33  
Dose 	 x 12.05 = 0.25 rem 
(Bone) 15.92 
*NOTE: ICRP 10 makes a mistake in calculating the dose to the bone. They 
calculated the whole body dose, but refer to it as bone dose. 
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050 
= 	  
% excretion 
x 28.1 rem 	 (from p. 12) 
A 
First year dose = 	
A 
x 2.63 qo rem 
% excretion 
B. Uptake Calculations From Excretion Data 
Evaluation of Uptake: The initial uptake qo may be determined by the excretion 
curves in ICRP 10A. 
Using the Power function model: (ICRP 10A) 
excretion at Day 1 
excretion at Day 2 




excretion at Day 365 = 0.0084% 
▪ Amt. of intake q = 	A  
o % excretion 
where A = Amt. of activity found in the Bioassay. 
For 90Sr: 
... The 50 year dose to the bone will be =  
	A 
% excretion 
The whole-body dose is approximately 5% more. 
Exponential Model 
x 39.4 rem 
To correlate intake and excretion, an excretion coefficient is defined as 
= fraction of uptake excreted in urine 
For any uranium, f,, = 85%, if u refers to amount found in urine 
fF = 15%, referring to fecal excretion 
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In reviewing radioisotopes of the same element, the excretion coefficients will be 
the same, as long as materials in the same lung class are compared. Excretion 
coefficients have been tabulated by Lessard et al. (5), either as such or in terms of an 
inverse quality, the Intake Retention Function (IRF). 
CALCULATION OF ALI AND Dso 
The above comparison showed that there was no particular benefit in using a 
power function relationship, except at very small values of t, and it was decided to adopt 
the exponential ICRP 30 model for all cases considered. 
A two-stage calculation was performed: 
a) calculation of intake values for each nuclide for a given excretion (urinary) 
activity; and 
b) calculation of fractional ALI and critical organ dose for that intake value, all 
normalized to unit activity in the urine sample. 
Table 3 gives an example of the data base available for excretion data (5) and 
Tables 4 and 5 present examples for the data base for intake retention function, ALI 
and committed dose equivalent for the various lung classes (4, 5), as well as Derived 
Investigation Levels (DIL). 
These data were used to calculate lung doses for single intake events which are 
tabulated in Tables 8 - 36. 
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TABLE 3 
Example of Excretion Data (5) 
ELEMENT DATA SHEET 
ELEMENT: Uranium 
PARTICLE SIZE: 1.0E+00 Microns 
LUNG DEPOSITION: Nasal Trachea and Pulmonary 
Passages Bronchial Tree Parenchyma 
3.10E - 01 8.00E-02 2.49E-01 







FRACTION FROM GI TRACT TO BLOOD (fil: 	5.00E-02 Ingestion 
5.00E-02 Class D 	 5.00E-02 Class W 	 2.00E-03 Class Y 
FRACTION OF SYSTEMIC UPTAKE EXCRETED THROUGH URINE (f ul: 	1.0E+00 











EXAMPLE OF DATA BASE FOR D50 AND ALI (4) NEPTUNIUM 
Committed Dose Equivalent in Target Organs or Tissues 
Per Intake of Unit Activity (Sv/Bq) of Np-237) 
ORAL 	 INHALATION 
CLASS W 
f1 = 1.E-02 	 f1 = 1.E-02 
GONADS 	 GONADS 
2.5E-06 3.1E-05 
R. MARROW 	 R. MARROW 
1.5E-05 	 1.9E-04 
BONE SURF. 	 BONE SURF. 
1.9E-04 	 2.4E-03 
LIVER 	 LIVER 
4.1E-05 5.1E-04 
Weighted Committed Dose Equivalent in Target Organs or Tissues 
Per Intake of Unit Activity (Sv/Bq) of Np-237 
ORAL 	 INHALATION 
CLASS W 
fl = 1.E-02 	 f1 = 1.E-02 
GONADS 	 GONADS 
6.1E-07 7.7E-06 
R. MARROW 	 R. MARROW 
1.8E-06 	 2.3E-05 
BONE SURF. 	 BONE SURF. 
5.7E-06 	 7.2E-05 
LIVER 	 LIVER 
2.5E-06 3.1E-05 
Annual Limits On Intake, ALI, And Derived Air 
Concentrations, DAC, (40 hr/wk) For Np-237) 
ALI (Bq) 	 DAC (Bq/m3)  
ORAL 	 INHALATION 	INHALATION 
CLASS W 	 CLASS W 
f1 = 1.E-02 	 f1 = 1.E-02 f1 = 1.E-02 
3.E 03 	 2.E 02 	 9.E-02 
(5.E 03) (4.E 02) 
BONE SURF. 	BONE SURF. 
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Table 5 
Example of Data Base for Intake Retention Function (TRF) (5) 















U-238, Class M Inhalation, ALI = 2.52E+04 Bq 
1.0 2.11E-01 5.57E-01 4.13E-02 4.37E+00 1.15E+01 8.55E-01 
5.0 1.45E-01 2.03E-01 2.69E-03 1.50E+01 2.10E+01 2.79E-01 
10.0 1.32E-01 1.59E-01 1.75E-03 2.73E+01 3.29E+01 3.62E-01 
30.0 1.02E-01 1.17E-01 7.28E-04 6.34E+01 7.27E+01 4.52E-01 
100.0 4.18E-02 4.81E-02 2.43E-04 8.66E+01 9.96E+01 5.03E-01 
200.0 1.15E-02 1.57E-02 7.49E-05 4.76E+01 6.50E+01 3.10E-01 
365.0 1.66E-03 5.14E-03 1.29E-05 1.25E+01 3.89E+01 9.75E-02 
U-238, Class Y Inhalation, ALI = 1.51E+03 Bq 
1.0 	2.13E-01 	5.85E-01 	2.23E-03 2.64E-01 7.26E-01 2.77E-03 
5.0 1.53E-01 1.83E-01 1.31E-04 9.49E-01 1.14E+00 8.13E-04 
10.0 1.48E-01 1.50E-01 8.42E-05 1.84E+00 1.86E+00 1.04E-03 
3u.0 1.45E-01 1.46E-01 3.27E-05 5.40E+00 5.43E+00 1.22E-03 
100.0 1.35E-01 1.35E-01 1.87E-U5 1.68E+01 1.68E+01 2.32E-03 
200.0 1.22E-01 1.22E-01 1.81E-05 3.02E+01 3.03E+01 4.49E-03 
365.0 1.03E-01 1.04E-01 1.82E-05 4.67E+01 4.71E+01 8.26E-03 
U-238, 
1.0 
Ingestion, ALI = 7.33E+06 Bq 
7.01E-01 	2.76E-01 4.22E+03 1.66E+03 
5.0 3.37E-02 2.89E-02 1.02E+03 8.71E+02 
10.0 1.23E-02 2.00E-04 7.41E+02 1.20E+01 
30.0 5.14E-03 0.00 9.29E+02 0.00 
100.0 1.50E-03 9.04E+02 
200.0 1.18E-03 1.42E+03 
3b5.0 1.14E-03 2.51E+03 
Pu-239, Class W Inhalation, ALI = 2.03E+02 Bq 
1.0 	2.11E-01 	5.96E-01 	2.83E-04 3.52E -02 9.94E-02 4.72E-05 
5.0 1.45E-01 2.45E-01 5.39E-05 1.21E-01 2.04E-01 4.50E-05 
10.0 1.32E-01 2.09E-01 2.54E-05 2.20E-01 3.49E-01 4.24E-05 
30.0 1.02E-01 1.86E-01 1.76E-05 5.11E-01 9.31E-01 8.81E-05 
100.0 4.18E-02 1.42E-01 1.12E-05 6.97E-01 2.37E+00 1.87E-04 
200.0 1.15E-02 1.21E-01 7.89E-06 3.84E-01 4.04E+00 2.63E-04 
365.0 1.66L-03 1.14E-01 4.96E -06 1.01E-01 6.94E+00 3.02E-04 
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EXPLANATION OF THE TABLES 
One of the first practical problems is to define the nature of the excretion sample. 
In practical cases of unanticipated inhalation events, it is usually desirable to obtain a 
bioassay sample within 24 hours and this may be followed up by other samples over a 
longer period of time. Since the lung class indicates the typical time period of lung 
clearance to the kidney, the first 48 hours are of greatest interest for Class D material; 
longer sampling times may be appropriate for the other classes. Because the first 
sample usually would represent cumulative appearance of excreta in the bladder up to 
the time of voiding, Column 2 in the tables (Tables 9 - 36) represents the cumulative 
fraction available for excretion at that time (5). These figures incorporate any 
correction for radioactive decay and as long as one can assume that samples are assayed 
shortly after collection, no further decay correction will be needed. If more than one 
sample is obtained during the first 24 hours, these samples must use the difference in 
excretion fractions. After the first day, tabulated excretion fractions, as shown in 
Column 3, refer to the total activity obtained over any 24-hour period only, preceding 
time T. Using this information, Column 4 inverts those data to list the intake quantity, 
in becquerels (Bq), per unit activity (Bq) measured in the urine. Taking the published 
ALI data, Column 5 presents the fraction of ALI incurred per unit of urine activity 
measured at that time T. The sixth column lists the committed dose equivalent to the 
target organ, in sieverts (Sv) per becquerel detected in the urine sample, using the 
conversion factors for committed dose equivalent in the ICRP 30 Supplements. The 
20 
Weighted Committed Dose Equivalent per Bq detected is given in Column 7, again 
using data from ICRP 30 Supplements. 
Inspection of the tables shows an initial decrease in the fraction of ALI incurred 
for a given amount of activity found in the urine. After a time commensurate with the 
clearance half life, that fraction increases rapidly, because for that activity still to be 
excreted after a longer period than the clearance half life, correspondingly larger 
amounts must have been deposited in the body and, consequently, higher lung doses 
have been incurred. This is illustrated in Figure 4 for the case of Class D Iodine-131. 
USE OF THE TABLES IN APPENDIX A 
To use these tables, one needs to measure the urine activity and note the 
collection ending time For example, three days after intake a 24 hour urine sample has 
an activity of 1000 Bq. To find the intake, one would simply multiply the 4th column by 
1000 to estimate the intake. To know what fraction of ALI that would represent, 
multiply the 5th column by 1000, and so on. It is necessary to know the lung class of the 
particlates to select the correct table. 
One may estimate the dose from just one measurement, but it is recommended to 
make several equally spaced measurements, as there may be some short-term changes 
in metabolic conditions. This may affect some data points; therefore CHI-square 




















--- 1 I 	• 




























'1 , i 	' 












1 1 	; 














! 	1. 	. 
I 
• I. 	1 
,. ■ 1 




1 . ' 



















i 	i l l' 
. 	il " 
; i 	i 
l l; 
, 	! III 	i ',I 





















' I. I 





'I I I 	
Ii . 1 , 	itT, 
I 






















I I 	1 1 	' 
.,1,  II 1 . , ,, ,. I jl 
1 1 	( 
1 	HI 
t 









'11 1 t 
. 1 	1 
. 	I 11 1 : HI; 
I 	'  ,1., 1 
; 	! 	IT ,ti II II ; 	II .1' II 
, I '!' 
it 11 














 I II :. 1, 11'I '. 1.i : . 
I.I. 
' 	,11 1 
11 1 11 1 1 Hi 	11 
1 
I " IL 
1111!" 
I 1 	11 i! 
l' 	IL T 























TT`i .11 . 	. 
_ 





















i_:.' I I 














I I I 
' 
. 
, . 	- 































, 	!  In iHI i l l .  1 
HI II 	I II I! I 
I . 	I; 












I li Hi. 1 !! :1; ; ; 
! 















II ; 	; T 
, .. 





1 	i i i! IIt 
- - . 
-I- 
IIII 
I 	I rl 
. I 
! 1 	I 
I; 	LijI 
















I 	: 	" 






I ! 1 
I 
I  I . 
III 	. 









I 1  
I 
1 










! I 	I 









.1 	i ; 
H 
;I., 






















































9 	 "A 	 ii 	 n 
Time After Single-Intake (Days) 
Figure 4: Fraction of ALI per Bq Excreted vs. Sample Time for 1-131 
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When a urine sample is taken, it is important to know the collection time. It is 
also necessary to collect all of the urine excreted in the 24- hour sample. If some urine 
is lost, then an estimate is needed to normalize the sample into a 24-hour sample. 
Suppose, a person has excreted four times a day, but only the first and third samples are 
available. Roughly, this would represent half of the urine sample of the 24-hour urine 
sample. The total activity of the urine should be multiplied by two to normalize the 
sample to a 24-hour effective sample. To improve accuracy, additional samples should 
then be obtained. If the urine sample is not counted immediately after collection, a 
decay correction may be necessary as the tabulated collection time T is assumed to be 
close to the counting time. It should be noted that the decay of the parent may lead to 
an activity of a daughter. Thus, if the time of waiting to be counted is long, further 
decay corrections and ingrowth may have to be considered. 
It may become necessary to make corrections for particle size, if it is other than 1 
1.1m AMAD. ICRP 30 and NUREG/CR-4884 (5) provide a procedure to correct that. 
As discussed below, it should be noted that these tables give estimates for a single 
intake only. If there were multiple intakes or continuous intake, NUREG/CR 4884 (5) 
also provides a way to correct for that. 
Sometimes it may be necessary to interpolate, especially for Class Y 
radionuclides. It is recommended to use exponential regression. The excretion values 
may be fitted to an exponential curve 
y = a exp (bt) 
where 
t = time after intake in days 
y = fraction of intake appearing in urine in time t 
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a and b are constants determined from exponential regression. It is also recommended 
to check RP, the regression coefficient. If R is 1±0.80 or above, then the data points 
have high correlation. 
Example: 
A 24 hour excretion value of Co-60, Class Y at t = 1 day is 4.65 E-03. Suppose it is 
desired to know the excretion value at t = 2 days. Excretion values for t = 3 days and t 
= 4 days are 2.4 E-03 and 1.28 E-03, respectively. 
The data points are (1, In 4.65 E-03), (3, In 2.4 E-03) and (4, In 1.28 E-03). 
The Rp for this set of data is -0.9846 indicating high correlation among the data 
points. The equation is 
y = 0.007354 exp - (0.4158t) 
at t = 2 days, 	y = 0.007354 exp - (0.4158x2) = 3.20 E-03 
i.e. the 3rd column gives 3.20 E-03 at t = 2 days. 
Best Estimate of Intake  
Values for best estimate of intake were based on the minimum value of chi-
squared, )(2, which is defined as the ratio of the sum of the squares of the differences 
between measured values, A(i), and the expectation values, (R 1 ), and the variance, 
Vi2 — 2.80, 
x2 = A(i) - (R11)2/Vi2  and dx2/dI = 0. 





A (i) = 
R (i) = 
At (i) = 
A (i) = 








best estimate of intake (pg or Bq), 
sample measurement (jig or Bq), 
fraction of intake in accumulated urine at time of ith sampling. (Given 
in Ref. 5). 
to - t(i-1) 
c(i) x 1.4 Lid t(;) 
AA (1) + AA(2) + ....AA(i) 
sequence no. of sample, 
time post intake for ith sampling (days), 
concentration of element, e.g. uranium in urine from ith sampling 
(pg/liter), 
AA(i) 	= uranium in ith sample of urine (Ag) 
A(i) = uranium in accumulated urine up to time = t(i) 
By inspection, it is evident that the earlier data are weighed more heavily. The 
reason behind that is that a significant percentage of the activity is excreted in the first 
few days and is statistically more reliable. 
It may be noted that where there is only one sample available, the equation 
reduces to a simple form. 
For one sample i = 1, 
I= 1 
R 1 . A 1  . 	R 1 A 1 =A 
R 2 R 1
2 	l 	RI  
The term 1/R1 appears in the tables in Column 5 and again Al is the activity of the 
sample. 
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The alternative method described above becomes an increasingly better estimate 
of the intake as the number of samples get larger. Since it is weighted, a short-term 
change in metabolic activity does not affect the value of the intake. Short-term changes 
may give rise to a very large error. 
A less complicated method than the alternative method above is to evaluate the 
intake by using the Tables in Appendix A provided and then take the mean of all 
intakes. A comparison of both methods shows that they give similar results. Once the 
best estimate of intake is known, one may multiply the intake with the dose conversion 
factor which appears at the top of each table. This procedure should be followed to 
determine the ultimate dose. The tables provide dose estimation just from one 
measurement in order to provide early information to indicate if any protective action 
should be taken. 
In order to use the above equation, one needs to know the fraction of intake 
accumulated in urine. These are found in Ref. 5. 
Detail of Calculations  
Step 1  
Ati = ti - ti_l 	 i = 1 	 Sample #1 
Ati = 0.2 - 0 = 0.2 days 
AAi = Ci x 1.4 L/day x Ati from Reference Man (14) 
AA1 = 6,100 x 1.4 x 0.2 = 1708 Ag 
Al = 1700 	 Presented in Column #5 
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Step 2 
Ati = ti - 	 i = 2 	 Sample #2 
t2 = 0.6 - 0.2 = 0.4 days 
AAi = Ci x 1.4 L/day x A ti 	i =2 
AA2 = (990 x 1.4 x 0.4) pg 
AA2 = 554.4 
Ai = AA1 + A2 . . . . AAi 
A3 = 554.4 + 1708 = 2262 - 2300 	 Column c. 2nd row 
Step 3  
Same as Above 
A4 = 2500 
A5 = 2700 
The Dunning report (6) lists data in mrem/pCi; these have to be converted into Bq of 
intake to be used in this tabulation. Also, correction for particle size is needed to 
obtain correct intake value. 
PARTICLE-SIZE CORRECTIONS 
According to ICRP 30, after a short time post single intake, the following 
approximate relationship exists between the total body intake retention function (IRF) 
for aerosols between 0.2 and 10 pm 
IRF (1 	
DN_p  IRF (AMAD) 
pm) = 
	[ fN_p x,„H5OT u 
4 n5OT w
WT
T x ON-P kl
(AMAD) 
 Am/ 
DT— (1 Ict (AMAD) , I-150T T  x w 	DT B 	AM) 




X  H5OT WT  x PAP. 
fP - 2 H5OT WT DP 	(I 
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where IRF (AMAD) = 	Total IRF for inhalation of D, W, Y compound 
of aerosol of interest. 
IRF (1 Am) = 	Total IRF for 1µm AMAD particle for D, W, Y 
fN-13, fT-13, fp = 	The fraction of committed dose equivalent in the tissue T 
resulting from deposition in the N-P, T-B & P Regions 
respectively, as defined in ICRP 30. 
Hso WT = 	 The weighted committed dose equivalent in Tissue T per 
unit intake. 
DN_p, DT_B and Dp = Regional deposition fractions for an aerosol entering the 
respiratory tract. 
The time when Eq. 1 is valid will differ for the various classes: 
Class 	 Time when Eq. 1 is valid 
D Less than 1 day 
W 	 7 days post intake 
Y 9 days post intake 
Values for EN-p, IT-B, fp and HSOT WT are given in supplements of ICRP 30 (3) 
DN_p DT_B and DP are listed in Table 6 for various AMAD values. 
ADDITIONAL COMMENTS 
URANIUM 
Only intake by inhalation is considered here. Several simplifying assumptions are 
used in the ICRP 30 model, e.g. the lung clearance classifications (D, W, and Y) are 
known, and particle size distributions have a characteristic 1.0 Am activity median 
aerosol dynamic diameter (AMAD). However, very often the actual particle size 
distribution is not known. Using Reference Man (14), one assumes a daily urinary 
excretion of 1.4 L/d. 
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TABLE 6 
REGIONAL DEPOSITION FRACTIONS FOR AEROSOLS WITH 
AMADs BETWEEN 0.2 AND 10 Am. (Ref. 5) 
Aerosol AMAD, Am 
0.2 0.5 0.7 1 
DN..p 4.98E-02 1.61E-01 2.27E-01 3.10E-01 
D -r_B 8.00E-02 8.00E-02 8.00E-02 8.00E-02 
Dp 5.00E-01 3.50E-01 2.99E-01 1.67E-01 
Total 
Deposition 6.30E-01 5.91E-01 6.06E-01 6.68E-01 
Aerosol AMAD, Am 
2 5 7 10 
Dti_p 5.00E-01 7.44E-01 8.14E-01 8.75E-01 
DT_B 8.00E-02 8.00E-02 8.00E-02 8.00E-02 
Dp 1.67E-01 8.80E-02 6.74E-02 4.98E-02 
Total 
Deposition 6.68E-01 9.12E-01 9.61E-01 1.00E-00 
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For uranium, an appropriate bioassay technique is in vivo lung monitoring for class 
W and class Y compounds, and urinary measurement, for class D. For class W and Y, 
the intake retention fraction for the 24-hour urine compartment decreases rapidly, and 
low levels of natural uranium in urine make it difficult to estimate an accidental 
exposure. Thus in vivo lung monitoring should be chosen for class W and Y 
compounds. Later the intake retention fraction for lung is given and finally the dose 
commitment is calculated. 
Because of the long half lives, decay corrections are not needed for U-234, 235 and 
238. The best estimate of the intake is calculated first, and the Dunning Report (6) can 
be used to calculate effective dose equivalent. The Dunning Report gives doses for 
AMAD values of 0.3, 0.5 and 1.0 pm and the appropriate value must be selected. The 
tables (Tables 19-29) are set up for 1 pm AMAD. 
Table 7 lists internal retention factors (IRF) for the lung for U-2385. The same 
procedure applies for other uranium isotopes. 
HIGHLY ENRICHED MATERIAL 
As a special case, a material containing 93% 235U, 6% 238U and 1% 233U was 
analyzed. 
Total Activity Detected in Urine = 


























Lungs , 	 Urine 
24-Hour 
Lungs 	Urine 
1 2.22E-01 1.87E-01 2.11E-01 4.13E-02 2.14E-01 2.28E-03 
5 1.65E-01 1.31E-02 1.45E-01 2.69E-03 1.53E-01 1.28E-04 
10 1.21E-01 7.26E-03 1.32E-01 1.75E-03 1.49E-01 8.26E-05 
20 7.36E-02 3.26E-03 1.16E-01 1.03E-03 1.47E-01 4.62E-05 
100 1.47E-02 1.11E-04 4.18E-02 2.43E-04 1.35E-01 1.87E-05 
Additionally, the ALI's for uranium 238 are 5E+ 04 Bq for Class D, 3E+ 04 for Class W 
and 2E+ 03 for Class Y aerosols having an AMAD of 1 micrometer. The minimum 
detection limit for daily urine sampling is typically 7 ug (1.7E-02 Bq), and for in vivo 












1n2 (0.93) 	1n2 (0.06) 	1n2 (0.01)  
= 9.29 E-16 Bq/g A
TOTAL 	2.22 E16 sec 1.0 E17 sec 
+




TOTAL X 100% 





TOTAL X 100% 





TOTAL X 100% 





Committed Dose equivalent H is calculated as follows: 
H 	= H x %A 	+ H %A 	+ H x%A 
mixture 	234 	234 235 235 238 	238 
U-238 contribution to the total dose is very small and may be neglected. The dose 
equivalent to the lungs is essentially due to U-234 in the mixture, but because of the U-
235 component, the dose in the mixture is about 0.5% lower than from U-234 alone. 
For example, at t = 1.00 E-01 days committed dose equivalent for the mixture is 
1.31 E-05 Sv per Bq excreted; committed dose equivalent for U-234 at t = 1.00 E-01 
day is 1.32 E-05 Sv per Bq excreted. At t = 3.00 E + 01 days, committed dose equivalent 
for mixture is 1.86 E-04 Sv per Bq excreted. Therefore, for the mixture, U-234 data 
alone may be used and lead to reasonably acceptable results. 
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PLUTONIUM 
Urinary monitoring for Pu-239 is a good choice, if sufficient sensitivity is available. 
Modern radiochemical separation of Pu in urine, in the presence of uranium, has a 
minimum detectable activity (MDA) of 90 attocuries per liter for a 24-hour urine 
sample. ANSI N13.30 (16) has the equations for bioassay. This technique relies on 
activation by of neutrons and the fissioning of Pu. However, with attocurie sensitivity 
for urine with 1.0 E-04 to 1.0 E-07 of the activity inhaled, several urinary measurements 
are needed in order to reduce the order of uncertainty associated with variation of Pu 
excretion due to diet. Because ALI is based on radiotoxic effects to bone, urinary 
monitoring is more appropriate than feces monitoring, which may be associated mainly 
with lung or GI deposition of Pu. (3) Lung counting is not recommended for routine 
bioassay procedure. The draft ANSI 13.30 standard, "Performance criteria for 
Radiobioassay," specifies the MDA to be 190 Bq/L of x-rays per nuclear transformation 
for lung counting for transuranics (16). For the reported L x-ray yield of Pu-239 of 4.24 
(5), this corresponds to an MDA of 4.4 kBq. Based upon approximately 15% of intake 
of Pu of class W and class Y compounds expected to be present in lungs after 7 days, 
this corresponds to a minimum detectable intake of 2.9E+04 Bq. Class W and class Y 
ALIs for Pu-239 are respectively 200 Bq and 500 Bq. Minimum detectable intake 
corresponds to 150 ALI for class W and 56 ALI for class Y compounds of Pu-239. 
Hence, lung counting is useful only for large accidental exposures. Urinary monitoring 
is a good way of monitoring, if sufficient sensitivity is available. 
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ICRP 48 (15) gives a retention model for Pu that is based on data for several 
mammalian species, including Langham's data for man. This model does not consider 
excretion explicitly and is not intended as a bioassay model. There are many power 
function excretion curves (modifications of Langham model) which give similar results. 
All of these apply to chronic exposures of Pu, which are not of interest here. 
The ICRP 30 model gives a fairly good estimate of intakes from excretion 
fractions, when corrected for particle size and adjusting intake estimates for an accurate 
time post intake. There is also a correction factor for single versus multiple exposures. 
However, as Table 8 shows, there are some differences in the fractional retention 
coefficient f1 between ICRP 30 and 48. 
Best estimate of intake is based on x2 statistics. So, even if a different model is 
adopted for excretion fractions, the method will still be the same. 
CONCLUSION 
The purpose of this work was the compilation of tables to simplify the estimation 
of worker's dose commitment and ALI detriment following accidental inhalation of 
radioactive airborne materials. The following tables, Tables 9-36, present numerical 
data for this purpose and should serve as reference data for most anticipated inhalation 
accident scenarios. Appendix B presents the flow sheet used in setting up the computer 
model employed in these calculations. 
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TABLE 8 
COMPARISON OF PROPOSED VALUES FOR F1 WITH 
THOSE RECOMMENDED IN ICRP PUBLICATION 30 (FROM REF. 15) 
fl X 10 4 
ELEMENT TYPE OF EXPOSURE, COMPOUND ICRP 48 ICRP 30 
Pu Occupational exposure 
oxides, 	including 
polydisperse oxides 0-1 0-1 
nitrates 
other compounds or unknown 
1 1 
mixtures 10 1 
Pu Population exposure (via food 
chains) all 	compounds 10 
Np Occupational 	and population 
exposure all compounds 10 100 
Am 
Cm 
Occupational 	and population 
exposure 
Cf all 	compounds 10 5 
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Table 9 
DOSE CALCULATION FOR INHALATION OF Co-60 PARTICULATES PER Bq EXCRETED 
Co-60 
	
T 1/2 = 1.92 E+03 Days 
	
Class - W 
AMAD - 1 micron 	ALI - 6 E+06 Bq 
	
Fu = 8.00 E-01 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lungs) = 3.6E-08 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 3.35E-03 2.98E+02 4.97E-05 1.07E-05 1.28E-06 
2.00E-01 7.09E-03 1.41E+02 2.35E-05 5.07E-06 6.06E-07 
3.00E-01 1.01E-02 9.90E+01 1.65E-05 3.56E-06 4.25E-07 
4.00E-01 1.29E-02 7.75E+01 1.29E-05 2.79E-06 3.33E-07 
5.00E-01 1.57E-02 6.36E+01 1.06E-05 2.29E-06 2.73E-07 
6.00E-01 1.81E-02 5.52E+01 9.20E-06 1.98E-06 2.37E-07 
7.00E-01 2.02E-02 4.95E+01 8.25E-06 1.78E-06 2.12E-07 
8.00E-01 2.23E-02 4.48E+01 7.47E-06 1.61E-06 1.92E-07 
9.00E-01 2.42E-02 4.13E+01 6.88E-06 1.48E-06 1.77E-07 
1.00E+00 2.59E-02 2.59E-02 3.86E+01 6.43E-06 1.38E-06 1.66E-07 
2.00E+00 1.10E-02 9.09E+01 1.51E-05 3.27E-06 3.90E-07 
3.00E+00 5.13E-03 1.94E+02 3.24E-05 7.01E-06 8.38E-07 
4.00E+00 3.05E-03 3.27E+02 5.46E-05 1.18E-05 1.40E-06 
5.00E+00 2.26E-03 4.42E+02 7.37E-05 1.59E-05 1.90E-06 
6.00E+00 1.90E-03 5.26E+02 8.77E-05 1.89E-05 2.26E-06 
7.00E+00 1.67E-03 5.98E+02 9.98E-05 2.15E-05 2.15E-05 
8.00E+00 1.51E-03 6.62E+02 1.10E-04 2.38E-05 2.84E-06 
9.00E+00 1.38E-03 7.24E+02 1.20E-04 2.60E-05 3.11E-06 
1.00E+01 1.27E-03 7.87E+02 1.31E-04 2.03E-05 3.38E-06 
2.00E+01 6.62E-04 1.51E+03 2.51E-04 5.43E-05 6.49E-06 
3.00E+01 4.48E-04 2.23E+03 3.72E-04 8.03E-05 9.59E-06 
4.00E+01 3.59E-04 2.78E+03 4.64E-04 1.00E-04 1.19E-05 
5.00E+01 3.11E-04 3.21E+03 5.35E-04 1.15E-04 1.38E-05 
6.00E+01 2.78E-04 3.59E+03 5.99E-04 1.29E-04 1.54E-05 
7.00E+01 2.50E-04 4.00E+03 6.66E-04 1.44E-04 1.72E-05 
8.00E+01 2.26E-04 4.42E+03 7.37E-04 1.59E-04 1.90E-05 
9.00E+01 2.05E-04 4.87E+03 8.13E-04 1.75E-04 2.09E-05 
1.00E+02 1.85E-04 5.40E+03 9.00E-04 1.94E-04 2.32E-05 
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Table 10 
DOSE CALCULATION FOR INHALATION OF Co-60 PARTICULATES PER Bq EXCRETED 
Co-60 	 Half Life - 1.22 E+03 Days 
	
Class - Y 
AMAD - 1 micron 	ALI - 1.0 E+06 Bq 
	
Fu = 8:00 E+01 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 3.4 E-07 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 1.92E-04 5.20E+03 5.20E-03 1.77E-03 2.13E-04 
2.00E-01 4.52E-04 2.21E+03 2.21E-03 7.52E-04 9.07E-05 
3.00E-01 7.90E-04 1.26E+08 1.26E-03 4.30E-04 5.18E-05 
4.00E-01 1.21E-03 8.26E+02 8.26E-04 2.80E-04 3.38E-05 
5.00E-01 1.71E-03 5.84E+02 5.84E-04 1.98E-04 2.39E-05 
6.00E-01 2.26E-03 4.42E+02 4.42E-04 1.50E-04 1.81E-05 
7.00E-01 2.85E-03 3.30E+02 3.50E-04 1.19E-04 1.43E-05 
8.00E-01 3.45E-03 2.89E+02 2.89E-04 9.85E-05 1.18E-05 
9.00E-01 4.05E-03 2.46E+02 2.46E-04 8.39E-05 1.01E-05 
1.00E+00 4.65E-03 4.65E-03 2.15E+02 2.15E-04 7.31E-05 8.81E-06 
2.00E+00 3.20E-03 3.12E+02 3.12E-04 1.00E-04 1.28E-05 
3.00E+00 2.40E-03 4.16E+02 4.16E-04 1.41E-04 1.70E-05 
4.00E+00 1.28E-03 4.81E+02 7.81E-04 2.65E-04 3.20E-05 
5.00E+00 8.18E-04 1.22E+03 1.22E-03 4.15E-04 5.01E-05 
6.00E+00 6.09E-04 1.64E+03 1.64E-03 5.58E-04 6.73E-05 
7.00E+00 4.98E-04 2.00E+03 2.00E-03 6.68E-04 8.23E-05 
8.00E+00 4.27E-04 2.43E+03 2.39E-03 7.96E-04 9.60E-05 
9.00E+00 3.75E-04 2.66E+03 2.66E-03 9.06E-04 1.09E-04 
1.00E+01 3.34E-04 2.99E+03 2.99E-03 1.01E-03 1.22E-04 
2.00E+01 1.29E-04 7.75E+03 7.75E-03 2.63E-03 3.17E-04 
3.00E+01 6.50E-05 1.53E+04 1.53E-02 5.23E-03 6.30E-04 
4.00E+01 4.37E-05 2.28E+04 2.28E-02 7.78E-03 9.38E-04 
5.00E+01 3.59E-05 2.78E+04 2.78E-02 9.47E-03 1.14E-03 
6.00E+01 3.24E-05 3.08E+04 3.08E-02 1.04E-02 1.26E-03 
7.00E+01 3.05E-05 3.27E+04 3.27E-02 1.11E-02 1.34E-03 
8.00E+01 2.91E-05 3.43E+04 3.43E-02 1.16E-02 1.40E-03 
9.00E+01 2.79E-05 3.58E+04 3.58E-02 1.21E-02 1.46E-03 
1.00E+02 2.70E-05 3.70E+04 3.70E-02 1.25E-02 1.51E-03 
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Table 11 
DOSE CALCULATION FOR INHALATION OF Sr-89 PARTICULATES PER Bq EXCRETED 
Sr-89 
	
T 1/2 = 5.05 E+01 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 0.3E+07 Bq 
	
Fu = 8.5 E-01 
Critical organ - red marrow 
Committed Dose Equivalent (EQ) (Red Marrow) = 5.6E-09 Sv/Bq 














Fraction Committed 	Wtd.Committed 
of ALI 	Dose Equiv. Dose Equiv. 
per Bq Marrow(Sv/Bq) Marrow(Sv/Bq) 
Excreted Excreted) 	Excreted) 
1.00E-01 2.57E-02 3.89E+01 1.29E-06 	2.17E-07 9.72E-09 
2.00E-01 3.81E-02 2.62E+01 8.74E-07 1.46E-07 6.56E-09 
3.00E-01 4.55E-02 2.19E+01 7.32E-07 1.23E-07 5.49E-09 
4.00E-01 5.21E-02 1.91E+01 6.39E-07 1.07E-07 4.79E-09 
5.00E-01 5.82E-02 1.71E+01 5.72E-07 9.62E-08 4.29E-09 
6.00E-01 6.40E-02 1.56E+01 5.20E-07 8.75E-08 3.90E-09 
7.00E-01 6.96E-02 1.43E+01 4.78E-07 8.04E-08 3.59E-09 
8.00E-01 7.51E-02 1.33E+01 4.43E-07 7.45E-08 3.32E-09 
9.00E-01 8.05E-02 1.24E+01 4.14E-07 6.95E-08 3.10E-09 
1.00E+00 8.57E-02 8.57E-02 1.16E+01 3.88E-07 6.53E-08 2.91E-09 
2.00E+00 4.63E-02 2.15E+01 7.19E-07 1.20E-07 5.39E-09 
3.00E+00 3.69E-02 2.71E+01 9.03E-07 1.51E-07 6.77E-09 
4.00E+00 2.98E-02 3.35E+01 1.11E-06 1.87E-07 8.38E-09 
5.00E+00 2.45E-02 4.08E+01 1.36E-06 2.28E-07 1.02E-08 
6.00E+00 2.04E-02 4.90E+01 1.63E-06 2.74E-07 1.22E-08 
7.00E+00 1.71E-02 5.84E+01 1.94E-06 3.27E-07 1.46E-08 
8.00E+00 1.44E-02 6.94E+01 2.31E-06 3.88E-07 1.73E-08 
9.00E+00 1.22E-02 8.19E+01 2.73E-06 4.59E-07 2.04E-08 
1.00E+01 1.04E-02 9.61E+01 3.20E-06 5.38E-07 2.40E-08 
2.00E+01 2.27E-03 4.40E+02 1.46E-05 2.46E-06 1.10E-07 
3.00E+01 6.22E-04 1.60E+03 5.35E-05 9.00E-06 4.01E-07 
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Table 12 
DOSE CALCULATION FOR INHALATION OF Sr-89 PARTICULATES PER Bq EXCRETED 
Sr-89 	 T 1/2 = 5.05 E+01 Days 
	
Class - Y 
AMAD - 1 micron 	ALI - 5.0 E+06 Bq 
	
Fu = 8.5 E-01 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lungs) = 8.4E-08 Sv/Bq 


























1.00E-01 4.19E-04 2.38E+03 4.77E-04 2.00E-04 2.38E-05 
2.00E-01 5.39E-04 1.85E+03 3.71E-04 1.55E-04 1.85E-05 
3.00E-01 6.36E-04 1.57E+03 3.14E-04 1.32E-04 1.57E-05 
4.00E-01 7.38E-04 1.35E+03 2.71E-04 1.13E-04 1.35E-05 
5.00E-01 8.44E-04 1.18E+03 2.36E-04 9.95E-05 1.18E-05 
6.00E-01 9.48E-04 1.05E+03 2.10E-04 8.86E-05 1.05E-05 
7.00E-01 1.05E-04 9.52E+02 1.90E-04 8.00E-05 9.52E-06 
8.00E-01 1.15E-03 8.69E+02 1.73E-04 7.30E-05 8.69E-06 
9.00E-01 1.24E-03 8.06E+02 1.61E-04 6.77E-05 8.06E-06 
1.00E+00 1.34E-03 1.34E-03 7.46E+02 1.49E-04 6.26E-05 7.46E-06 
2.00E+00 7.89E-04 1.26E+03 2.53E-04 1.06E-05 1.26E-05 
3.00E+00 6.22E-04 1.60E+03 3.21E-04 1.35E-04 1.60E-05 
4.00E+00 5.09E-04 1.96E+03 3.92E-04 1.64E-04 1.96E-05 
5.00E+00 4.22E-04 2.36E+03 4.73E-04 1.99E-04 2.36E-05 
6.00E+00 3.54E-04 2.82E+03 5.64E-04 2.37E-04 2.82E-05 
7.00E+00 2.99E-04 3.34E+03 6.68E-04 2.80E-04 3.34E-05 
8.00E+00 2.55E-04 3.92E+03 7.84E-04 3.29E-04 3.92E-05 
9.00E+00 2.18E-04 4.58E+03 9.17E-04 3.85E-04 4.58E-05 
1.00E+01 1.87E-04 5.34E+03 1.06E-03 4.49E-04 5.37E-05 
2.00E+01 5.07E-05 1.97E+04 3.94E-03 1.65E-03 1.97E-04 
3.00E+01 2.32E-05 4.31E+04 8.62E-03 3.62E-03 4.31E-04 
4.00E+01 1.75E-05 5.71E+04 1.14E-02 4.80E-03 5.71E-04 
5.00E+01 1.63E-05 6.13E+04 1.22E-02 5.15E-03 6.13E-04 
6.00E+01 1.59E-05 6.28E+04 1.25E-02 5.28E-03 6.28E-04 
7.00E+01 1.58E-05 6.32E+04 1.26E-02 5.31E-03 6.32E-04 
8.00E+01 1.57E-05 6.36E+04 1.27E-02 5.35E-03 6.36E-04 
9.00E+01 1.56E-05 6.41E+04 1.28E-02 5.38E-03 6.41E-04 
1.00E+02 1.56E-05 6.41E+04 1.28E-02 5.38E-03 6.41E-04 
42 
Table 13 
DOSE CALCULATION FOR INHALATION OF Sr-90 PARTICULATES PER Bq EXCRETED 
Sr-90 	 T 1/2 = 1.06 E+04 Days 
AMAD - 1 micron 	ALI - 7.0E+05 Bq 
Class - D 
Fu = 8.50 E-01 
Critical organ - red marrow 
Committed Dose Equivalent (EQ) (Red Marrow) = 3.3E-07 Sv/Bq 














Fraction Committed 	Wtd.Committed 
of ALI 	Dose Equiv. Dose Equiv. 
per Bq Marrow(Sv/Bq) Marrow(Sv/Bq) 
Excreted Excreted) 	Excreted) 
1.00E-01 2.75E-02 3.63E+01 5.19E-05 1.20E-05 1.45E-06 
2.00E-01 3.81E-02 2.62E+01 3.74E-05 8.66E-06 1.04E-06 
3.00E-01 4.55E-02 2.19E+01 3.13E-05 7.25E-06 8.79E-07 
4.00E-01 5.21E-02 1.91E+01 2.74E-05 6.33E-06 7.67E-07 
5.00E-01 5.82E-02 1.71E+01 2.45E-05 5.67E-06 6.87E-07 
6.00E-01 6.40E-02 1.56E+01 2.23E-05 5.15E-06 6.25E-07 
7.00E-01 6.96E-02 1.43E+01 2.05E-05 4.74E-06 5.74E-07 
8.00E-01 7.51E-02 1.33E+01 1.90E-05 4.39E-06 5.32E-07 
9.00E-01 8.05E-02 1.24E+01 1.77E-05 4.09E-06 4.96E-07 
1.00E+00 8.57E-02 8.57E-02 1.16E+01 1.66E-05 3.85E-06 4.66E-07 
2.00E+00 4.63E-02 2.15E+01 3.08E-05 7.12E-06 8.63E-07 
3.00E+00 3.69E-02 2.71E+01 3.87E-05 8.94E-06 1.08E-06 
4.00E+00 2.98E-02 3.35E+01 4.79E-05 1.10E-05 1.34E-06 
5.00E+00 2.03E-02 4.92E+01 7.03E-05 1.62E-05 1.97E-06 
6.00E+00 1.71E-02 5.84E+01 8.35E-05 1.92E-05 2.33E-06 
7.00E+00 1.44E-02 6.94E+01 9.92E-05 2.29E-05 2.77E-06 
8.00E+00 1.22E-02 8.19E+01 1.17E-04 2.70E-05 3.27E-06 
9.00E+00 1.04E-02 9.61E+01 1.37E-04 3.17E-05 3.84E-06 
1.00E+01 2.26E-02 4.42E+02 6.32E-04 1.46E-04 1.76E-05 
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Table 14 
DOSE CALCULATION FOR INHALATION OF Sr-90 PARTICULATES PER Bq EXCRETED 
Sr-90 	 Half Life - 1.06 E+04 Days 
	
Class - Y 
AMAD - 1 micron 	ALI - 1 E+05 Bq 
	
Fu = 8.50 E-01 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lungs) = 2.9E-06 Sv/Bq 


























1.00E-01 4.19E-04 2.38E+03 2.38E-02 6.92E-03 8.11E-04 
2.00E-01 5.39E-04 1.85E+03 1.85E-02 5.38E-03 6.30E-04 
3.00E-01 6.36E-04 1.57E+03 1.57E-02 4.55E-03 5.34E-04 
4.00E-01 7.38E-04 1.35E+03 1.35E-02 3.92E-03 4.60E-04 
5.00E-01 8.44E-04 1.18E+03 1.18E-02 3.43E-03 4.02E-04 
6.00E-01 9.48E-04 1.05E+03 1.05E-02 3.05E-03 3.58E-04 
7.00E-01 1.05E-04 9.52E+02 9.52E-03 2.76E-03 3.23E-04 
8.00E-01 1.15E-03 8.69E+02 8.69E-03 2.52E-03 2.95E-04 
9.00E-01 1.24E-03 8.06E+02 8.06E-03 2.33E-03 2.74E-04 
1.00E+00 1.34E-03 1.34E-03 7.46E+02 7.46E-03 2.16E-03 2.57E-04 
2.00E+00 7.89E-04 1.26E+03 1.26E-02 3.67E-03 4.30E-04 
3.00E+00 6.22E-04 1.60E+03 1.60E-02 4.66E-03 5.46E-04 
4.00E+00 5.09E-04 1.96E+03 1.96E-02 5.69E-03 6.67E-04 
5.00E+00 4.22E-04 2.36E+03 2.36E-02 6.87E-03 8.05E-04 
6.00E+00 3.54E-04 2.82E+03 2.82E-02 8.19E-03 9.60E-04 
7.00E+00 2.99E-04 3.34E+03 3.34E-02 9.69E-03 1.13E-03 
8.00E+00 2.55E-04 3.92E+03 3.92E-02 1.13E-02 1.33E-03 
9.00E+00 2.18E-04 4.58E+03 4.58E-02 1.33E-02 1.55E-03 
1.00E+01 1.87E-04 5.34E+03 1.06E-02 1.55E-02 1.81E-03 
2.00E+01 5.07E-05 1.97E+04 1.97E-01 5.71E-02 6.70E-03 
3.00E+01 2.32E-05 4.31E+04 4.31E-01 1.25E-01 1.46E-02 
4.00E+01 1.75E-05 5.71E+04 5.71E-01 1.65E-01 1.94E-02 
5.00E+01 1.63E-05 6.13E+04 6.32E-01 1.77E-01 2.08E-02 
6.00E+01 1.59E-05 6.28E+04 6.28E-01 1.82E-01 2.13E-02 
7.00E+01 1.58E-05 6.32E+04 6.32E-01 1.83E-01 2.15E-02 
8.00E+01 1.57E-05 6.36E+04 6.36E-01 1.84E-01 2.16E-02 
9.00E+01 1.56E-05 6.41E+04 6.41E-01 1.85E-01 2.17E-02 
1.00E+02 1.56E-05 6.41E+04 1.85E-01 1.85E-01 2.17E-02 
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Table 15 
DOSE CALCULATION FOR INHALATION OF 1-125 PARTICULATES PER Bq EXCRETED 
1-125 	 Half Life - 6.01 E+01 Days 	 Class - D 
AMAD - 1 micron 	ALI - 2.0 E+06 Bq 	 Fu = 9.7 E-01 
Critical organ - thyroid 
Committed Dose Equivalent (EQ) (Thyroid) = 2.2E-07 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Thyr.(Sv/8q) Thyr.(Sv/8q) 
Excreted) 	Excreted) 
1.00E-01 5.01E-02 1.97E+01 9.86E-06 4.33E-06 1.28E-07 
2.00E-01 1.09E-01 9.17E+00 4.58E-06 2.01E-06 5.96E-08 
3.00E-01 1.58E-01 6.32E+00 3.16E-06 1.39E-06 4.11E-08 
4.00E-01 2.00E-01 5.00E+00 2.50E-06 1.10E-06 3.25E-08 
5.00E-01 2.34E-01 4.27E+00 2.13E-06 9.40E-07 2.77E-08 
6.00E-01 2.63E-01 3.80E+00 1.90E-06 8.36E-07 2.47E-08 
7.00E-01 2.87E-01 3.48E+00 1.74E-06 7.66E-07 2.26E-08 
8.00E-01 3.08E-01 3.24E+00 1.62E-06 7.14E-07 2.11E-08 
9.00E-01 3.26E-01 3.06E+00 1.53E-06 6.74E-07 1.99E-08 
1.00E+00 3.41E-01 3.41E-01 2.93E+00 1.46E-06 6.45E-07 1.90E-08 
2.00E+00 7.63E-02 1.31E+01 6.55E-06 2.88E-06 8.51E-08 
3.00E+00 2.15E-02 4.65E+01 2.32E-05 1.02E-05 3.02E-07 
4.00E+00 6.51E-03 1.53E+02 7.68E-05 3.37E-05 9.98E-07 
5.00E+00 2.08E-03 4.80E+02 2.40E-04 1.05E-04 3.12E-06 
6.00E+00 8.09E-04 1.23E+03 6.18E-04 2.71E-04 8.03E-06 
7.00E+00 4.75E-04 2.10E+03 1.05E-03 4.63E-04 1.36E-05 
8.00E+00 4.12E-04 2.42E+03 1.21E-03 5.33E-04 1.57E-05 
9.00E+00 4.25E-04 2.35E+03 1.17E-03 5.17E-04 1.52E-05 
1.00E+01 4.57E-04 2.18E+03 1.09E-03 4.81E-04 1.42E-05 
2.00E+01 7.31E-04 1.36E+03 6.83E-04 3.00E-04 8.89E-06 
3.00E+01 8.54E-04 1.17E+03 5.85E-04 2.57E-04 7.61E-06 
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Table 16 
DOSE CALCULATION FOR INHALATION OF 1-131 PARTICULATES PER Bq EXCRETED 
1-131 	 Half Life - 8.04 E+01 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 2.0 E+06 Bq 
	
Fu = 9.7 E-01 
Critical organ - thyroid 
Committed Dose Equivalent (EQ) (Thyroid) = 2.9E-07 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Thyr.(Sv/Bq) Thyr.(Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 5.01E-02 1.99E+01 9.98E-06 5.78E-06 1.75E-07 
2.00E-01 1.09E-01 9.17E+00 4.58E-06 2.66E-06 8.07E-08 
3.00E-01 1.58E-01 6.32E+00 3.16E-06 1.83E-06 5.56E-08 
4.00E-01 2.00E-01 5.00E+00 2.50E-06 1.45E-06 4.40E-08 
5.00E-01 2.34E-01 4.27E+00 2.13E-06 1.23E-06 3.76E-08 
6.00E-01 2.63E-01 3.80E+00 1.90E-06 1.10E-06 3.34E-08 
7.00E-01 2.87E-01 3.48E+00 1.74E-06 1.01E-06 3.06E-08 
8.00E-01 3.08E-01 3.24E+00 1.62E-06 9.41E-07 2.85E-08 
9.00E-01 3.26E-01 3.06E+00 1.53E-06 8.89E-07 2.69E-08 
1.00E+00 3.41E-01 3.41E-04 2.93E+00 1.46E-06 8.50E-07 2.58E-08 
2.00E+00 7.63E-02 1.31E+01 6.55E-06 3.80E-06 1.15E-07 
3.00E+00 2.15E-02 4.65E+01 2.32E-05 1.34E-05 4.09E-07 
4.00E+00 6.51E-03 1.53E+02 7.68E-05 4.45E-05 1.35E-06 
5.00E+00 2.08E-03 4.80E+02 2.40E-04 1.39E-04 4.23E-06 
6.00E+00 8.09E-04 1.23E+03 6.18E-04 3.58E-04 1.08E-05 
7.00E+00 4.75E-04 2.10E+03 1.05E-03 6.10E-04 1.85E-05 
8.00E+00 4.12E-04 2.42E+03 1.21E-03 7.03E-04 2.13E-05 
9.00E+00 4.25E-04 2.35E+03 1.17E-03 6.82E-04 2.07E-05 
1.00E+01 4.57E-04 2.18E+03 1.09E-03 6.34E-04 1.92E-05 
2.00E+01 7.31E-04 1.36E+03 6.83E-03 3.96E-04 1.20E-05 
3.00E+01 8.54E-04 1.17E+03 5.85E-04 3.39E-04 1.03E-05 
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Table 17 
DOSE CALCULATION FOR INHALATION OF Cs-134 PARTICULATES PER Bq EXCRETED 
Cs-134 	 Half Life - 7.53 E+02 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 4.0 E+06 Bq 
	
Fu = 8.00 E-01 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lungs) = 1.2E-08 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) 	Lung (Sv/Bq) 
Excreted) Excreted) 
1.00E-01 9.20E-04 1.08E+03 2.71E-04 1.30E-05 1.52E-06 
2.00E-01 2.22E-03 4.50E+02 1.12E-04 5.40E-06 6.30E-07 
3.00E-01 3.58E-03 2.79E+02 6.98E-05 3.35E-06 3.91E-07 
4.00E-01 4.97E-03 2.01E+02 5.03E-05 2.41E-06 2.81E-07 
5.00E-01 6.38E-03 1.56E+02 3.91E-05 1.88E-06 2.19E-07 
6.00E-01 7.80E-03 1.28E+02 3.20E-05 1.53E-06 1.79E-07 
7.00E-01 9.22E-03 1.08E+02 2.71E-05 1.30E-06 1.51E-07 
8.00E-01 1.06E-02 9.43E+01 2.35E-05 1.13E-06 1.32E-07 
9.00E-01 1.21E-02 8.26E+01 2.06E-05 9.91E-07 1.15E-07 
1.00E+00 1.35E-02 1.35E-02 7.40E+01 1.85E-05 8.88E-07 1.03E-07 
2.00E+00 1.33E-02 7.51E+01 1.87E-05 9.02E-07 1.05E-07 
3.00E+00 1.10E-02 9.09E+01 2.27E-05 1.09E-06 1.27E-07 
4.00E+00 8.87E-03 1.12E+02 2.81E-05 1.35E-06 1.57E-07 
5.00E+00 7.16E-03 1.39E+02 3.49E-05 1.67E-06 1.95E-07 
6.00E+00 5.89E-03 1.69E+02 4.24E-05 2.03E-06 2.37E-07 
7.00E+00 4.98E-03 2.00E+02 5.02E-05 2.40E-06 2.81E-07 
8.00E+00 4.32E-03 2.31E+02 5.78E-05 2.77E-06 3.24E-07 
9.00E+00 3.85E-03 2.59E+02 6.49E-05 3.11E-06 3.63E-07 
1.00E+01 3.51E-03 2.84E+02 7.12E-05 3.41E-06 3.98E-07 
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Table 18 
DOSE CALCULATION FOR INHALATION OF Cs-137 PARTICULATES PER Bq EXCRETED 
Cs-137 
	
Half Life - 1.10 E+04 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 6.0 E+06 Bq 
	
Fu = 8.00 E-01 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lungs) = 8.8E-09 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted ) 
1.00E-01 9.20E-04 1.08E+03 1.81E-04 9.56E-06 1.19E-06 
2.00E-01 2.22E-03 4.50E+02 7.50E-05 3.96E-06 4.95E-07 
3.00E-01 3.58E-03 2.79E+02 4.65E-05 2.45E-06 3.07E-07 
4.00E-01 4.97E-03 2.01E+02 3.35E-05 1.77E-06 2.21E-07 
5.00E-01 6.38E-03 1.56E+02 2.61E-05 1.37E-06 1.72E-07 
6.00E-01 7.80E-03 1.28E+02 2.13E-05 1.12E-06 1.41E-07 
7.00E-01 9.22E-03 1.08E+02 1.80E-05 9.54E-07 1.19E-07 
8.00E-01 1.06E-02 9.43E+01 1.57E-05 8.30E-07 1.03E-07 
9.00E-01 1.21E-02 8.26E+01 1.37E-05 7.27E-07 9.09E-08 
1.00E+00 1.35E-02 1.35E-02 7.40E+01 1.23E-05 6.51E-07 8.14E-08 
2.00E+00 1.33E-02 7.51E+01 1.25E-05 6.61E-07 8.27E-08 
3.00E+00 1.10E-02 9.09E+01 1.51E-05 8.00E-07 1.00E-07 
4.00E+00 8.87E-03 1.12E+02 1.87E-05 9.92E-07 1.24E-07 
5.00E+00 7.16E-03 1.39E+02 2.32E-05 1.22E-06 1.53E-07 
6.00E+00 5.89E-03 1.69E+02 2.82E-05 1.49E-06 1.86E-07 
7.00E+00 4.97E-03 2.01E+02 3.35E-05 1.77E-06 2.21E-07 
8.00E+00 4.32E-03 2.31E+02 3.85E-05 2.03E-06 2.54E-07 
9.00E+00 3.85E-03 2.59E+02 4.32E-05 2.28E-06 2.85E-07 
1.00E+01 3.51E-03 2.84E+02 4.74E-05 2.50E-06 3.13E-07 
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Table 19 
DOSE CALCULATION FOR INHALATION OF U-233 PARTICULATES PER Bq EXCRETED 
U-233 
	
T 1/2 = 5.79 E+07 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 4 E+4 Bq 
	
Fu = 1.0 E+00 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lung) = 3.2E-07 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted ) 
1.00E-01 2.41E-02 41.32 1.03E-03 1.32E-05 1.61E-06 
2.00E-01 5.00E-02 20.00 5.00E-04 6.40E-06 7.80E-07 
3.00E-01 7.36E-02 13.59 3.40E-04 4.35E-06 5.30E-07 
4.00E-01 9.50E-02 10.53 2.63E-04 3.37E-06 4.11E-07 
5.00E-01 1.14E-01 8.77 2.19E-04 2.81E-06 3.42E-07 
6.00E-01 1.32E-01 7.58 1.90E-04 2.43E-06 2.96E-07 
7.00E-01 1.48E-01 6.76 1.69E-04 2.16E-06 2.64E-07 
8.00E-01 1.62E-01 6.17 1.54E-04 1.97E-06 2.41E-07 
9.00E-01 1.75E-01 5.71 1.43E-04 1.83E-06 2.23E-07 
1.00E+00 1.87E-01 1.87E-01 5.35 1.34E-04 1.71E-06 2.09E-07 
2.00E+00 7.27E-02 13.76 3.43E-04 4.39E-06 5.37E-07 
3.00E+00 3.21E-02 31.15 7.79E-04 9.97E-06 1.21E-06 
4.00E+00 1.82E-02 54.95 1.37E-03 1.76E-05 2.14E-06 
5.00E+00 1.31E-02 76.34 1.91E-03 2.44E-05 2.98E-06 
6.00E+00 1.09E-02 91.74 2.29E-03 2.94E-05 3.52E-06 
7.00E+00 9.64E-03 103.73 2.59E-03 3.32E-05 4.05E-06 
8.00E+00 8.71E-03 114.81 2.87E-03 3.67E-05 4.48E-06 
9.00E+00 7.94E-03 125.94 3.15E-03 4.03E-05 4.91E-06 
1.00E+01 7.26E-03 137.74 3.44E-03 4.41E-05 5.37E-06 
2.00E+01 3.26E-03 306.75 7.67E-03 9.82E-05 1.19E-06 
3.00E+01 1.71E-03 584.79 1.46E-02 1.87E-04 2.29E-05 
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Table 20 
DOSE CALCULATION FOR INHALATION OF U-233 PARTICULATES PER Bq EXCRETED 
U-233 
	
T 1/2 = 5.79 E+07 Days 
	
Class - W 
AMAD - 1 micron 	ALI - 3 E+04 Bq 
	
Fu = 1.0 E+00 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lung) = 1.6E-05 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 6.93E-03 1.44E+02 4.81E-03 2.30E-03 2.74E-04 
2.00E-01 1.37E-02 7.29E+02 2.43E-03 1.16E-03 1.38E-04 
3.00E-01 1.92E-02 5.20E+01 1.73E-03 8.33E-03 9.89E-05 
4.00E-01 2.40E-02 4.16E+01 1.38E-03 6.66E-03 7.91E-05 
5.00E-01 2.80E-02 3.57E+01 1.19E-03 5.71E-04 6.78E-05 
6.00E-01 3.15E-02 3.71E+01 1.05E-03 5.07E-04 6.03E-05 
7.00E-01 3.44E-02 2.90E+01 9.68E-04 4.65E-04 5.52E-05 
8.00E-01 3.70E-02 2.70E+01 9.00E-04 4.32E-04 5.13E-05 
9.00E-01 3.93E-02 2.54E+01 8.48E-04 4.07E-04 4.38E-05 
1.00E+00 4.13E-02 4.13E-02 2.42E+01 8.07E-04 3.87E-04 4.60E-05 
2.00E+00 1.09E-02 9.17E+01 3.05E-03 1.46E-03 1.74E-04 
3.00E+00 4.72E-03 2.11E+02 7.06E-03 3.38E-03 4.02E-04 
4.00E+00 3.22E-03 3.10E+02 1.03E-02 4.96E-03 5.90E-04 
5.00E+00 2.69E-03 3.71E+02 1.23E-02 5.94E-03 7.06E-04 
6.00E+00 2.40E-03 4.16E+02 1.38E-02 6.66E-03 7.91E-04 
7.00E+00 2.19E-03 4.56E+02 1.52E-02 7.30E-03 8.67E-04 
8.00E+00 2.02E-03 4.95E+02 1.65E-02 7.92E-03 9.40E-04 
9.00E+00 1.88E-03 5.31E+02 1.77E-02 8.51E-03 1.01E-03 
1.00E+01 1.75E-03 5.71E+02 1.90E-02 9.14E-03 1.08E-03 
2.00E+01 1.03E-03 9.70E+02 3.23E-02 1.55E-02 1.84E-03 
3.00E+01 7.28E-04 1.37E+03 4.57E-02 2.19E-02 2.60E-03 
4.00E+01 5.75E-04 1.73E+03 5.79E-02 2.78E-02 3.30E-03 
5.00E+01 4.80E-04 2.80E+03 6.94E-02 3.33E-02 3.95E-03 
6.00E+01 4.11E-04 2.43E+03 8.11E-02 3.89E-02 4.62E-03 
7.00E+01 3.57E-04 2.86E+03 9.33E-02 4.48E-02 5.32E-03 
8.00E+01 3.12E-04 3.20E+03 1.06E-01 5.12E-02 6.08E-03 
9.00E+01 2.75E-04 3.63E+03 1.21E-01 5.81E-02 6.90E-03 
1.00E+01 2.43E-04 4.11E+03 1.37E-01 6.58E-02 7.81E-03 
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Table 21 
DOSE CALCULATION FOR INHALATION OF U-234 PARTICULATES PER Bq EXCRETED 
U-234 	 Half Life - 8.94 E+07 Days 
AMAD - 1 micron 	ALI - 5 E+4 Bq 
Class - D 
F u = 1.0 E+00 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lung) = 3.2 x 10-7 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted ) 
1.00E-01 2.41E-02 41.32 8.26E-04 1.32E-05 1.57E-06 
2.00E-01 5.00E-02 20.00 4.00E-04 6.40E-06 7.6 E-07 
3.00E-01 7.36E-02 13.59 2.71E-04 4.34E-06 5.16E-07 
4.00E-01 9.50E-02 10.53 2.10E-04 3.36E-06 4.00E-07 
5.00E-01 1.14E-01 8.77 1.75E-04 2.80E-06 3.33E-07 
6.00E-01 1.32E-01 7.58 1.51E-04 2.42E-06 2.88E-07 
7.00E-01 1.48E-01 6.76 1.35E-04 2.16E-06 2.56E-07 
8.00E-01 1.62E-01 6.17 1.23E-04 1.97E-06 2.34E-07 
9.00E-01 1.75E-01 5.71 1.14E-04 1.82E-06 2.16E-07 
1.00E+00 1.87E-01 1.87E-01 5.35 1.07E-04 1.71E-06 2.03E-07 
2.00E+00 7.27E-02 13.76 2.71E-04 4.34E-06 5.15E-07 
3.00E+00 3.21E-02 31.15 6.23E-04 9.96E-06 1.18E-06 
4.00E+00 1.82E-02 54.95 1.09E-03 1.75E-05 2.08E-06 
5.00E+00 1.31E-02 76.34 1.52E-03 2.44E-05 2.90E-06 
6.00E+00 1.09E-02 91.74 1.83E-03 2.93E-05 3.48E-06 
7.00E+00 9.64E-03 103.73 2.07E-03 3.31E-05 3.94E-06 
8.00E+00 8.71E-03 114.81 2.29E-03 3.36E-05 4.36E-06 
9.00E+00 7.94E-03 125.94 2.51E-03 4.03E-05 4.78E-06 
1.00E+01 7.26E-03 137.74 2.75E-03 4.40E-05 5.23E-06 
2.00E+01 3.26E-03 306.75 6.13E-03 9.81E-05 1.16E-05 
3.00E+01 1.71E-03 584.79 1.16E-02 1.87E-04 2.22E-05 
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Table 22 
DOSE CALCULATION FOR INHALATION OF U-234 PARTICULATES PER Bq EXCRETED 
U-234 
	
T 1/2 = 8.94 E+07 Days 
	
Class - W 
AMAD - 1 micron 	ALI - 1.0E+03 Bq 
	
Fu = 1.0 E+00 
Critical organ - lungs 
Committed Dose Equivalent (EQ) (Lung) = 1.6E-05 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) 	Lung (Sv/Bq) 
Excreted) Excreted) 
1.00E-01 6.93E-03 1.44E+02 4.81E-03 2.30E-03 2.74E-04 
2.00E-01 1.37E-02 7.29E+02 2.43E-03 1.16E-03 1.38E-04 
3.00E-01 1.92E-02 5.20E+01 1.73E-03 8.33E-03 9.89E-05 
4.00E-01 2.40E-02 4.16E+01 1.38E-03 6.66E-04 7.91E-05 
5.00E-01 2.80E-02 3.57E+01 1.19E-03 5.71E-04 6.78E-05 
6.00E-01 3.15E-02 3.71E+01 1.05E-03 5.07E-04 6.03E-05 
7.00E-01 3.44E-02 2.90E+01 9.68E-04 4.65E-04 5.52E-05 
8.00E-01 3.70E-02 2.70E+01 9.00E-04 4.32E-04 5.13E-05 
9.00E-01 3.93E-02 2.54E+01 8.48E-04 4.07E-04 4.38E-05 
1.00E+00 4.13E-02 4.13E-02 2.42E+01 8.07E-04 3.87E-04 4.60E-05 
2.00E+00 1.09E-02 9.17E+01 3.05E-03 1.46E-03 1.74E-04 
3.00E+00 4.72E-03 2.11E+02 7.06E-03 3.38E-03 4.02E-04 
4.00E+00 3.22E-03 3.10E+02 1.03E-02 4.96E-03 5.90E-04 
5.00E+00 2.69E-03 3.71E+02 1.23E-02 5.94E-03 7.06E-04 
6.00E+00 2.40E-03 4.16E+02 1.38E-02 6.66E-03 7.91E-04 
7.00E+00 2.19E-03 4.56E+02 1.52E-02 7.30E-03 8.67E-04 
8.00E+00 2.02E-03 4.95E+02 1.65E-02 7.92E-03 9.40E-04 
9.00E+00 1.88E-03 5.31E+02 1.77E-02 8.51E-03 1.01E-03 
1.00E+01 1.75E-03 5.71E+02 1.90E-02 9.14E-03 1.08E-03 
2.00E+01 1.03E-03 9.70E+02 3.23E-02 1.55E-02 1.84E-03 
3.00E+01 7.28E-04 1.37E+03 4.57E-02 2.19E-02 2.60E-03 
4.00E+01 5.75E-04 1.73E+03 5.79E-02 2.78E-02 3.30E-03 
5.00E+01 4.80E-04 2.80E+03 6.94E-02 3.33E-02 3.95E-03 
6.00E+01 4.11E-04 2.43E+03 8.11E-02 3.89E-02 4.62E-03 
7.00E+01 3.57E-04 2.86E+03 9.33E-02 4.48E-02 5.32E-03 
8.00E+01 3.12E-04 3.20E+03 1.06E-01 5.12E-02 6.08E-03 
9.00E+01 2.75E-04 3.63E+03 1.21E-01 5.81E-02 6.90E-03 
1.00E+01 2.43E-04 4.11E+03 1.37E-01 6.58E-02 7.81E-03 
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Table 23 
DOSE CALCULATION FOR INHALATION OF U-234 PARTICULATES PER Bq EXCRETED 
U-234 	 Half Life - 8.94 E+07 Days 	 Class - Y 
AMAD - 1 micron 	ALI - 1.0 E+03 Bq 	 Fu = 1:00 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 3.0 E-04 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted 	Excreted ) 
1.00E-01 3.80E-04 2.63E+03 2.63E+00 7.89E-01 9.47E-02 
2.00E-01 7.49E-04 1.33E+03 1.33E+00 4.00E-01 4.80E-02 
3.00E-01 1.05E-03 9.52E+02 9.52E-01 2.85E-01 3.42E-02 
4.00E-01 1.31E-03 7.63E+02 7.63E-01 2.29E-01 2.74E-02 
5.00E-01 1.53E-03 6.53E+02 6.53E-01 1.96E-01 2.35E-02 
6.00E-01 1.71E-03 5.84E+02 5.84E-01 1.75E-01 2.10E-02 
7.00E-01 1.87E-03 5.34E+02 5.34E-01 1.60E-01 1.92E-02 
8.00E-01 2.01E-03 4.97E+02 4.97E-01 1.49E-01 1.79E-02 
9.00E-01 2.13E-03 4.69E+02 4.69E-01 1.40E-01 1.69E-02 
1.00E+00 2.23E-03 2.23E-03 4.48E+02 4.48E-01 1.34E-01 1.61E-02 
2.00E+00 5.49E-04 1.82E+03 1.82E+00 5.46E-01 6.55E-02 
3.00E+00 2.30E-04 4.34E+03 4.34E+00 1.30E+00 1.56E-01 
4.00E+00 1.57E-04 6.36E+03 6.36E+00 1.91E+00 2.29E-01 
5.00E+00 1.31E-04 7.63E+03 7.63E+00 2.29E+00 2.74E-01 
6.00E+00 1.17E-04 8.54E+03 8.54E+00 2.56E+00 3.07E-01 
7.00E+00 1.07E-04 9.34E+03 9.34E+00 2.80E+00 3.36E-01 
8.00E+00 9.81E-05 1.01E+04 1.01E+01 3.05E+00 3.66E-01 
9.00E+00 9.07E-05 1.10E+04 1.10E+01 3.30E+00 3.96E-01 
1.00E+01 8.42E-05 1.18E+04 1.18E+01 3.56E+00 4.27E-01 
2.00E+01 4.69E-05 2.13E+04 2.13E+01 6.39E+00 7.67E-01 
3.00E+01 3.27E-05 3.05E+04 3.05E+01 9.17E+00 1.10E+00 
4.00E+01 2.65E-05 3.77E+04 3.77E+01 1.13E+01 1.35E+00 
5.00E+01 2.34E-05 4.27E+04 4.27E+01 1.28E+01 1.53E+00 
6.00E+01 2.20E-05 4.54E+04 4.54E+01 1.36E+01 1.63E+00 
7.00E+01 2.04E-05 4.90E+04 4.90E+01 1.47E+01 1.76E+00 
8.00E+01 1.96E-05 5.10E+04 5.10E+01 1.53E+01 1.83E+00 
9.00E+01 1.91E-05 5.23E+04 5.23E+01 1.57E+01 1.88E+00 
1.00E+02 1.87E-05 5.34E+04 5.34E+01 1.60E+01 1.92E+00 
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Table 24 
DOSE CALCULATION FOR INHALATION OF U-235 PARTICULATES PER Bq EXCRETED 
U-235 	 T 1/2 = 2.57 E+11 Days 
AMAD - 1 micron 	ALI - 5 E+04 Bq 
Class - D 
F u = 1.00 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 2.8E-07 Sv/Bq inhaled 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 2.41E-02 41.32 8.26E-04 1.19E-05 1.44E-06 
2.00E-01 5.00E-02 20.00 4.00E-04 5.80E-06 7.00E-07 
3.00E-01 7.36E-02 13.59 2.71E-04 3.94E-06 4.75E-07 
4.00E-01 9.50E-02 10.53 2.10E-04 3.05E-06 3.68E-07 
5.00E-01 1.14E-01 8.77 1.75E-04 2.54E-06 3.06E-07 
6.00E-01 1.32E-01 7.58 1.51E-04 2.19E-06 2.65E-07 
7.00E-01 1.48E-01 6.76 1.35E-04 1.96E-06 2.36E-07 
8.00E-01 1.62E-01 6.17 1.23E-04 1.78E-06 2.15E-07 
9.00E-01 1.75E-01 5.71 1.14E-04 1.65E-06 1.99E-07 
1.00E+00 1.87E-01 1.87E-01 5.35 1.07E-04 1.55E-06 1.87E-07 
2.00E+00 7.27E-02 13.76 2.75E-04 3.99E-06 4.81E-07 
3.00E+00 3.21E-02 31.15 6.23E-04 9.03E-06 1.09E-06 
4.00E+00 1.82E-02 54.95 1.09E-03 1.59E-05 1.92E-06 
5.00E+00 1.31E-02 76.34 1.52E-03 2.21E-05 2.67E-06 
6.00E+00 1.09E-02 91.74 1.83E-03 2.66E-05 3.21E-06 
7.00E+00 9.64E-03 103.73 2.07E-03 3.00E-05 3.63E-06 
8.00E+00 8.71E-03 114.81 2.29E-03 3.32E-05 4.01E-06 
9.00E+00 7.94E-03 125.94 2.51E-03 3.65E-05 4.40E-06 
1.00E+01 7.26E-03 137.74 2.75E-03 3.99E-05 4.82E-06 
2.00E+01 3.26E-03 306.75 6.13E-03 8.89E-05 1.07E-05 
3.00E+01 1.71E-03 584.79 1.16E-03 1.69E-04 2.04E-05 
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Table 25 
DOSE CALCULATION FOR INHALATION OF U-235 PARTICULATES PER Bq EXCRETED 
U-235 	 T 1/2 = 2.57 E+11 Days 
	
Class - W 
AMAD - 1 micron 	ALI - 3 E+04 Bq 
	
Fu = 1.00 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 1.5E-05 Sv/Bq 


























1.00E-01 6.93E-03 1.44E+02 4.81E-03 2.16E-03 2.59E-04 
2.00E-01 1.37E-02 7.29E+01 2.43E-03 1.09E-03 1.31E-04 
3.00E-01 1.92E-02 5.20E+01 1.73E-03 7.81E-04 9.37E-05 
4.00E-01 2.40E-02 4.16E+01 1.38E-03 6.25E-04 7.50E-05 
5.00E-01 2.80E-02 3.57E+01 1.19E-03 5.35E-04 6.42E-05 
6.00E-01 3.15E-02 3.17E+01 1.05E-03 4.76E-04 5.71E-05 
7.00E-01 3.44E-02 2.90E+01 9.68E-04 4.36E-04 5.23E-05 
8.00E-01 3.70E-02 2.70E+01 9.00E-04 4.05E-04 4.86E-05 
9.00E-01 3.93E-02 2.54E+01 8.48E-04 3.81E-04 4.58E-05 
1.00E+00 4.13E-02 4.13E-02 2.42E+01 8.07E-04 3.63E-04 4.35E-05 
2.00E+00 1.09E-02 9.17E+01 3.05E-03 1.37E-03 1.65E-04 
3.00E+00 4.72E-03 2.11E+02 7.06E-03 3.17E-03 3.81E-04 
4.00E+00 3.22E-03 3.10E+02 1.03E-02 4.65E-03 5.59E-04 
5.00E+00 2.69E-03 3.71E+02 1.23E-02 5.57E-03 6.69E-04 
6.00E+00 2.40E-03 4.16E+02 1.38E-02 6.25E-03 7.50E-04 
7.00E+00 2.19E-03 4.56E+02 1.52E-02 6.84E-03 8.21E-04 
8.00E+00 2.02E-03 4.95E+02 1.65E-02 7.42E-03 8.91E-04 
9.00E+00 1.80E-03 5.31E+02 1.77E-02 7.97E-03 9.57E-04 
1.00E+01 1.75E-03 5.71E+02 1.90E-02 8.75E-03 1.02E-03 
2.00E+01 1.03E-03 9.70E+02 3.23E-02 1.45E-02 1.74E-03 
3.00E+01 7.28E-04 1.37E+03 4.57E-02 2.06E-02 2.47E-03 
4.00E+01 5.75E-04 1.73E+03 5.79E-02 2.60E-02 3.13E-03 
5.00E+01 4.80E-04 2.08E+03 6.94E-02 3.12E-02 3.74E-03 
6.00E+01 4.11E-04 2.43E+03 8.11E-02 3.64E-02 4.37E-03 
7.00E+01 3.57E-04 2.80E+03 9.33E-02 4.20E-02 5.04E-03 
8.00E+01 3.12E-04 3.20E+03 1.06E-01 4.81E-02 5.76E-03 
9.00E+01 2.75E-04 3.63E+03 1.21E-01 5.45E-02 6.54E-03 
1.00E+02 2.43E-04 4.11E+03 1.37E-01 6.17E-02 7.40E-03 
55 
Table 26 
DOSE CALCULATION FOR INHALATION OF U-235 PARTICULATES FOR Bq EXCRETED 
U-235 	 Half Life - 2.57 E+11 Days 
	
Class - Y 
AMAD - 1 micron 	ALI - 2 E+03 Bq 
	
Fu = 1.00 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 2.8 E-04 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted ) 
1.00E-01 3.80E-04 2.63E+03 1.31E+00 7.36E-01 8.68E-02 
2.00E-01 7.49E-04 1.33E+03 6.67E-01 3.77E-01 4.40E-02 
3.00E-01 1.05E-03 9.52E+02 4.76E-01 2.66E-01 3.14E-02 
4.00E-01 1.31E-03 7.63E+02 3.81E-01 2.13E-01 2.51E-02 
5.00E-01 1.53E-03 6.53E+02 3.26E-01 1.83E-01 2.15E-02 
6.00E-01 1.71E-03 5.84E+02 2.92E-01 1.63E-01 1.92E-02 
7.00E-01 1.87E-03 5.34E+02 2.67E-01 1.49E-01 1.76E-02 
8.00E-01 2.01E-03 4.97E+02 2.48E-01 1.39E-01 1.64E-02 
9.00E-01 2.13E-03 4.69E+02 2.34E-01 1.31E-01 1.54E-02 
1.00E+00 2.23E-03 2.23E-03 4.48E+02 2.24E-01 1.95E-01 1.47E-02 
2.00E+00 5.49E-04 1.82E+03 9.10E-01 5.10E-01 6.01E-02 
3.00E+00 2.30E-04 4.34E+03 2.17E+00 1.21E+00 1.43E-01 
4.00E+00 1.57E-04 6.36E+03 3.18E+00 1.78E+00 2.10E-01 
5.00E+00 1.31E-04 7.63E+03 3.81E+00 2.13E+00 2.51E-01 
6.00E+00 1.17E-04 8.54E+03 4.27E+00 2.39E+00 2.82E-01 
7.00E+00 1.07E-04 9.04E+03 4.67E+00 2.61E+00 3.08E-01 
8.00E+00 9.81E-05 1.01E+04 5.09E+00 2.58E+00 3.36E-01 
9.00E+00 9.07E-05 1.10E+04 5.51E+00 3.08E+00 5.63E-01 
1.00E+01 8.42E-05 1.18E+04 5.93E+00 3.32E+00 3.91E-01 
2.00E+01 4.69E-05 2.13E+04 1.06E+01 5.97E+00 7.03E-01 
3.00E+01 3.27E-05 3.05E+04 1.52E+01 8.56E+00 1.00E+00 
4.00E+01 2.65E-05 3.77E+04 1.88E+01 1.05E+01 1.24E+00 
5.00E+01 2.34E-05 4.27E+04 2.13E+01 1.19E+01 1.41E+00 
6.00E+01 2.19E-05 4.56E+04 2.28E+01 1.27E+01 1.50E+00 
7.00E+01 2.04E-05 4.90E+04 2.45E+01 1.37E+01 1.61E+00 
8.00E+01 1.96E-05 5.10E+04 2.55E+01 1.42E+01 1.68E+00 
9.00E+01 1.91E-05 5.23E+04 2.61E+01 1.46E+01 1.72E+00 
1.00E+02 1.87E-05 5.34E+04 2.67E+01 1.49E+01 1.76E+00 
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Table 27 
DOSE CALCULATION FOR INHALATION OF U-238 PARTICULATES PER Bq EXCRETED 
U-238 	 Half Life - 1.64 E+12 Days 
	
Class - D 
AMAD - 1 micron 	ALI - 5 E+4 Bq 
	
Fu = 1.0 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 2.8E-07 Sv/Bq 


























1.00E-01 2.41E-02 41.32 8.26E-04 1.16E-05 1.40E-06 
2.00E-01 5.00E-02 20.00 4.00E-04 5.60E-06 6.80E-07 
3.00E-01 7.36E-02 13.59 2.71E-04 3.81E-06 4.62E-07 
4.00E-01 9.50E-02 10.53 2.11E-04 2.94E-06 3.58E-07 
5.00E-01 1.14E-01 8.77 1.75E-04 2.46E-06 2.98E-07 
6.00E-01 1.32E-01 7.58 1.51E-04 2.12E-06 2.58E-07 
7.00E-01 1.48E-01 6.76 1.35E-04 1.89E-06 2.30E-07 
8.00E-01 1.62E-01 6.17 1.23E-04 1.73E-06 2.10E-07 
9.00E-01 1.75E-01 5.71 1.14E-04 1.60E-06 1.94E-07 
1.00E+00 1.87E-01 1.87E-01 5.35 1.07E-04 1.50E-06 1.82E-07 
2.00E+00 7.27E-02 13.76 2.75E-04 3.84E-06 9.67E-07 
3.00E+00 3.21E-02 31.15 6.23E-04 8.72E-06 1.06E-06 
4.00E+00 1.82E-02 54.95 1.10E-03 1.54E-05 1.87E-06 
5.00E+00 1.31E-02 76.34 1.53E-03 2.14E-05 2.60E-06 
6.00E+00 1.09E-02 91.74 1.83E-03 2.57E-05 3.12E-06 
7.00E+00 9.64E-03 103.73 2.07E-03 2.90E-05 3.53E-06 
8.00E+00 8.71E-03 114.81 2.30E-03 3.21E-05 3.9 E-06 
9.00E+00 7.94E-03 125.94 2.52E-03 3.53E-05 4.28E-06 
1.00E+01 7.26E-03 137.74 2.75E-03 3.86E-05 4.68E-06 
2.00E+01 3.26E-03 306.75 6.14E-03 8.59E-05 1.04E-05 
3.00E+01 1.71E-03 584.79 1.17E-03 1.64E-04 1.99E-05 
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Table 28 
DOSE CALCULATION FOR INHALATION OF U-238 PARTICULATES PER Bq"EXCRETED 
U-238 	 Half Life - 1.64 E+12 days 
	
Class - W 
AMAD - 1 micron 	ALI - 3 E+04 Bq 
	
Fu = 1.0 E+00 
Critical organ = lungs 
Committed Dose Equivalent (EQ) (Lung) = 1.4E-05 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Lung (Sv/Bq) Lung (Sv/Bq) 
Excreted) 	Excreted ) 
1.00E-01 6.93E-03 1.44E+02 4.81E-03 2.02E-03 2.45E-04 
2.00E-01 1.37E-02 7.29E+01 2.43E-03 1.02E-03 1.24E-04 
3.00E-01 1.92E-02 5.20E+01 1.73E-03 7.29E-04 8.85E-05 
4.00E-01 2.40E-02 4.16E+01 1.38E-03 5.83E-04 7.08E-05 
5.00E-01 2.80E-02 3.57E+01 1.19E-03 4.79E-04 6.07E-05 
6.00E-01 3.15E-02 3.17E+01 1.05E-03 4.44E-04 5.39E-05 
7.00E-01 3.44E-02 2.90E+01 9.68E-04 4.06E-04 4.74E-05 
8.00E-01 3.70E-02 2.70E+01 9.00E-04 3.78E-04 4.59E-05 
9.00E-01 3.93E-02 2.54E+01 8.48E-04 3.56E-04 4.32E-05 
1.00E+00 4.13E-02 4.13E-02 2.42E+01 8.07E-04 3.38E-04 4.11E-05 
2.00E+00 1.09E-02 9.17E+01 3.05E-03 1.28E-03 1.55E-04 
3.00E+00 4.72E-02 2.11E+02 7.06E-03 2.96E-03 3.60E-04 
4.00E+00 3.22E-02 3.10E+02 1.03E-02 4.34E-03 5.27E-04 
5.00E+00 2.96E-03 3.71E+02 1.23E-02 5.20E-03 6.31E-04 
6.00E+00 2.40E-03 4.16E+02 1.38E-02 5.83E-03 7.08E-04 
7.00E+00 2.19E-03 4.56E+02 1.52E-02 6.39E-03 7.76E-04 
8.00E+00 2.02E-03 4.95E+02 1.65E-02 6.93E-03 8.41E-04 
9.00E+00 1.88E-03 5.31E+02 1.77E-02 7.44E-03 9.04E-04 
1.00E+01 1.75E-03 5.71E+02 1.90E-02 8.00E-03 9.71E-04 
2.00E+01 1.03E-03 9.70E+02 3.23E-02 1.35E-02 1.65E-03 
3.00E+01 7.28E-04 1.37E+03 4.57E-02 1.92E-02 2.33E-03 
4.00E+01 5.75E-04 1.73E+03 5.79E-02 2.43E-02 2.95E-03 
5.00E+01 4.80E-04 2.08E+03 6.94E-02 2.91E-02 3.54E-03 
6.00E+01 4.11E-04 2.43E+03 8.11E-02 3.40E-02 4.13E-03 
7.00E+01 3.57E-04 2.80E+03 9.34E-02 3.92E-02 4.76E-03 
8.00E+01 3.12E-04 3.20E+03 1.06E-01 4.48E-02 5.44E-03 
9.00E+01 2.75E-04 3.63E+03 1.21E-01 5.09E-02 6.18E-03 
1.00E+02 2.43E-04 4.11E+03 1.37E-01 5.76E-02 6.99E-03 
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Table 29 
DOSE CALCULATION FOR INHALATION OF U-238 PARTICULATES PER Bq EXCRETED 
U-238 	 Half Life - 1.64 E+12 Days 
	
Class - Y 
AMAD - 1 micron 	ALI - 2 E+03 Bq 
	
Fu = 1.00E+00 
Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 2.7E-04 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Bone (Sv/Bq) Bone (Sv/Bq) 
Excreted 	Excreted) 
1.00E-01 3.80E-04 2.63E+03 1.31E+00 7.10E-01 8.42E-02 
2.00E-01 7.49E-04 1.33E+03 6.67E-01 3.60E-01 4.27E-02 
3.00E-01 1.05E-03 9.52E+02 4.76E-01 2.57E-01 3.04E-02 
4.00E-01 1.31E-03 7.63E+02 3.81E-01 2.06E-01 2.44E-02 
5.00E-01 1.53E-03 6.53E+02 3.26E-01 1.76E-01 2.09E-02 
6.00E-01 1.71E-03 5.84E+02 2.92E-01 1.57E-01 1.87E-02 
7.00E-01 1.87E-03 5.34E+02 2.07E-01 1.44E-01 1.71E-02 
8.00E-01 2.01E-03 4.97E+02 2.48E-01 1.34E-01 1.59E-02 
9.00E-01 2.13E-03 4.69E+02 2.34E-01 1.26E-01 1.50E-02 
1.00E+00 2.23E-03 2.23E-03 4.48E+02 2.24E-01 1.21E-01 1.43E-02 
2.00E+00 5.49E-03 1.82E+02 9.10E-01 4.91E-01 5.82E-02 
3.00E+00 2.30E-04 4.34E+03 2.17E+00 1.17E+00 1.39E-01 
4.00E+00 1.57E-04 6.36E+03 3.18E+00 1.71E+00 2.03E-01 
5.00E+00 1.31E-04 7.36E+03 3.81E+00 2.06E+00 2.44E-01 
6.00E+00 1.17E-04 8.54E+03 4.27E+00 2.30E+00 2.73E-01 
7.00E+00 1.07E-04 9.34E+03 4.67E+00 2.52E+00 2.99E-01 
8.00E+00 9.81E-05 1.02E+04 5.09E+00 2.75E+00 3.26E-01 
9.00E+00 9.07E-05 1.10E+04 5.51E+00 2.97E+00 3.52E-01 
1.00E+01 8.42E-05 1.18E+04 5.93E+00 3.20E+00 3.80E-01 
2.00E+01 4.69E-05 2.13E+04 1.06E+01 5.75E+00 6.82E-01 
3.00E+01 3.27E-05 3.05E+04 1.52E+01 8.25E+00 9.78E-01 
4.00E+01 2.65E-05 3.77E+04 1.88E+01 1.01E+01 1.20E+00 
5.00E+01 2.34E-05 4.27E+04 2.13E+01 1.15E+01 1.36E+00 
6.00E+01 2.19E-05 4.56E+04 2.28E+01 1.23E+01 1.46E+00 
7.00E+01 2.04E-05 4.90E+04 2.45E+01 1.32E+01 1.56E+00 
8.00E+01 1.96E-05 5.10E+04 2.55E+01 1.37E+01 1.63E+00 
9.00E+01 1.91E-05 5.23E+04 2.61E+01 1.41E+01 1.67E+00 
1.00E+02 1.87E-05 5.34E+04 2.67E+01 1.44E+01 1.71E+00 
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Table 30 
DOSE CALCULATION FOR INHALATION OF Pu-238 PARTICULATES PER BQ EXCRETED 
Pu-238 	 Half Life - 3.20 E+04 Days 
AMAD - 1 micron 	ALI - 2 E+02 Bq 
Class - W 
Fu = 5.4 E-01 
Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 2.2E-03 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Bone (Sv/Bq) Bone (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-00 3.05E-05 3.27E+04 1.63E+02 7.21E+01 2.16E+00 
2.00E-00 6.46E-05 1.54E+04 7.73E+02 3.40E+01 1.02E+00 
3.00E-00 9.69E-05 1.03E+04 5.15E+01 2.27E+01 6.81E-01 
4.00E-00 1.28E-04 7.81E+03 3.90E+01 1.71E+01 5.15E-01 
5.00E-00 1.57E-04 6.36E+03 3.18E+01 1.40E+01 4.20E-01 
6.00E-00 1.85E-04 5.40E+03 2.70E+01 1.18E+01 3.56E-01 
7.00E-00 2.11E-04 4.73E+03 2.36E+01 1.09E+01 3.12E-01 
8.00E-00 2.36E-04 4.23E+03 2.11E+01 9.32E+00 2.79E-01 
9.00E-00 2.60E-04 3.84E+03 1.92E+01 8.46E+00 2.53E-01 
1.00E+00 2.83E-04 2.83E-04 3.53E+03 1.76E+01 7.77E+00 2.31E-01 
2.00E+00 1.76E-04 5.68E+03 2.84E+01 1.25E+01 3.75E-01 
3.00E+00 1.12E-04 8.92E+03 4.46E+01 1.96E+01 5.89E-01 
4.00E+00 7.53E-05 1.32E+04 6.64E+01 2.92E+01 8.76E-01 
5.00E+00 5.39E-05 1.85E+04 9.27E+01 4.08E+01 1.22E+00 
6.00E+00 4.15E-05 2.40E+04 1.20E+02 5.30E+01 1.59E+00 
7.00E+00 3.42E-05 2.92E+04 1.46E+02 6.43E+01 1.92E+00 
8.00E+00 2.98E-05 3.55E+04 1.67E+02 7.38E+01 2.21E+00 
9.00E+00 2.71E-05 3.69E+04 1.84E+02 8.11E+01 2.43E+00 
1.00E+01 2.54E-05 3.93E+04 1.96E+02 8.66E+01 2.59E+00 
2.00E+01 2.01E-05 4.97E+04 2.48E+02 1.09E+02 3.28E+00 
3.00E+01 1.76E-05 5.68E+04 2.84E+02 1.25E+02 3.75E+00 
4.00E+01 1.58E-05 6.32E+04 3.16E+02 1.39E+02 4.17E+00 
5.00E+01 1.45E-05 6.89E+04 3.44E+02 1.51E+02 4.55E+00 
6.00E+01 1.36E-05 7.35E+04 3.67E+02 1.61E+02 4.85E+00 
7.00E+01 1.28E-05 7.81E+04 3.90E+02 1.71E+02 5.15E+00 
8.00E+01 1.22E-05 8.19E+04 4.09E+02 1.80E+02 5.40E+00 
9.00E+01 1.16E-05 8.62E+04 4.31E+02 1.89E+02 5.68E+00 
1.00E+02 1.11E-05 9.00E+04 4.50E+02 1.98E+02 5.94E+00 
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Table 31 
DOSE CALCULATION FOR INHALATION OF Pu-238 PARTICULATES PER Bq EXCRETED 
Pu-238 
	
Half Life - 2.20 E+04 Days 
	
Class - Y 
AMAD - 1 micron 
	
ALI - 6 E+02 Bq 
	
Fu = 5.4 E-01 
Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 6.6E-05 Sv/Bq 


























1.00E-01 1.68E-06 5.95E+05 9.92E+02 3.92E+01 4.76E+00 
2.00E-01 3.55E-06 2.81E+05 4.69E+02 1.85E+01 2.25E+00 
3.00E-01 5.32E-06 1.87E+05 3.13E+02 1.24E+01 1.50E+00 
4.00E-01 7.01E-06 1.42E+05 2.37E+02 9.41E+00 1.14E+00 
5.00E-01 8.61E-06 1.16E+05 1.93E+02 7.66E+00 9.92E-01 
6.00E-01 1.01E-05 9.90E+04 1.65E+02 6.53E+00 7.92E-01 
7.00E-01 1.16E-05 8.62E+04 1.43E+02 5.69E+00 6.89E-01 
8.00E-01 1.30E-05 7.69E+04 1.28E+02 5.07E+00 6.15E-01 
9.00E-01 1.43E-05 6.99E+04 1.16E+02 4.61E+00 5.59E-01 
1.00E+00 1.55E-05 1.55E-05 6.45E+04 1.07E+02 4.25E+00 5.16E-01 
2.00E+00 9.64E-06 1.03E+05 1.72E+02 6.89E+00 8.29E-01 
3.00E+00 6.09E-06 1.64E+05 2.73E+02 1.08E+01 1.31E+00 
4.00E+00 4.09E-06 2.44E+05 4.07E+02 1.61E+01 1.95E+00 
5.00E+00 2.87E-06 3.48E+05 5.80E+02 2.29E+01 2.78E+00 
6.00E+00 2.18E-06 4.58E+05 7.64E+02 3.02E+01 3.66E+00 
7.00E+00 1.78E-06 5.61E+05 9.36E+02 3.70E+01 4.49E+00 
8.00E+00 1.53E-06 6.53E+05 1.08E+03 4.31E+01 5.22E+00 
9.00E+00 1.38E-06 7.24E+05 1.20E+03 4.78E+01 5.79E+00 
1.00E+01 1.29E-06 7.75E+05 1.29E+03 5.11E+01 6.20E+00 
2.00E+01 1.00E-06 1.00E+06 1.66E+03 6.60E+01 8.66E+00 
3.00E+01 8.80E-06 1.13E+06 1.89E+03 7.49E+01 9.09E+01 
4.00E+01 8.04E-06 1.24E+06 2.07E+03 8.20E+01 9.95E+01 
5.00E+01 7.56E-07 1.32E+06 2.20E+03 8.73E+01 1.05E+01 
6.00E+01 7.27E-07 1.37E+06 2.29E+03 9.07E+01 1.10E+01 
7.00E+01 7.11E-07 1.40E+06 2.34E+03 9.28E+01 1.12E+01 
8.00E+01 7.02E-07 1.42E+06 2.37E+03 9.40E+01 1.13E+01 
9.00E+01 6.98E-07 1.43E+06 2.38E+03 9.45E+01 1.14E+01 
1.00E+01 6.97E-07 1.93E+06 2.39E+03 9.46E+01 1.14E+01 
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Table 32 
DOSE CALCULATION FOR INHALATION OF Pu-239 PARTICULATES PER BQ EXCRETED 
Pu-239 	 Half Life - 8.78 E+06 Days 
	
Class - W 
AMAD - 1 micron 	ALI - 2 E+02 Bq 
	
Fu = 5.4 E-01 
Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 2.5E-03 Sv/Bq 


























1.00E-00 3.05E-05 3.27E+04 1.63E+02 8.19E+01 2.42E+00 
2.00E-00 6.46E-05 1.54E+04 7.73E+02 3.38E+01 1.14E+00 
3.00E-00 9.69E-05 1.03E+04 5.15E+01 2.57E+01 7.63E-01 
4.00E-00 1.28E-04 7.81E+03 3.90E+01 1.95E+01 5.78E-01 
5.00E-00 1.57E-04 6.36E+03 3.18E+01 1.59E+01 4.71E-01 
6.00E-00 1.85E-04 5.40E+03 2.70E+01 1.35E+01 4.00E-01 
7.00E-00 2.11E-04 4.73E+03 2.36E+01 1.18E+01 3.50E-01 
8.00E-00 2.36E-04 4.23E+03 2.11E+01 1.05E+01 3.13E-01 
9.00E-00 2.60E-04 3.84E+03 1.92E+01 9.61E+00 2.84E-01 
1.00E+00 2.83E-04 2.83E-04 3.53E+03 1.77E+01 8.83E+00 2.61E-01 
2.00E+00 1.76E-04 5.68E+03 2.84E+01 1.42E+01 4.20E-01 
3.00E+00 1.12E-04 8.93E+03 4.46E+01 2.23E+01 6.61E-01 
4.00E+00 7.53E-05 1.33E+04 6.64E+01 3.33E+01 9.84E-01 
5.00E+00 5.39E-05 1.85E+04 9.28E+01 4.65E+01 1.37E+00 
6.00E+00 4.15E-05 2.41E+04 1.21E+02 6.03E+01 1.78E+00 
7.00E+00 3.42E-05 2.92E+04 1.46E+02 7.30E+01 2.16E+00 
8.00E+00 2.98E-05 3.36E+04 1.68E+02 8.40E+01 2.49E+00 
9.00E+00 2.71E-05 3.69E+04 1.85E+02 9.23E+01 2.73E+00 
1.00E+01 2.54E-05 3.94E+04 1.97E+02 9.85E+01 2.91E+00 
2.00E+01 2.01E-05 4.98E+04 2.49E+02 1.25E+02 3.69E+00 
3.00E+01 1.76E-05 5.68E+04 2.84E+02 1.42E+02 4.20E+00 
4.00E+01 1.58E-05 6.33E+04 3.17E+02 1.58E+02 4.68E+00 
5.00E+01 1.45E-05 6.90E+04 3.45E+02 1.73E+02 5.11E+00 
6.00E+01 1.36E-05 7.35E+04 3.68E+02 1.84E+02 5.44E+00 
7.00E+01 1.28E-05 7.81E+04 3.91E+02 1.95E+02 5.78E+00 
8.00E+01 1.22E-05 8.02E+04 4.10E+02 2.01E+02 6.10E+00 
9.00E+01 1.16E-05 8.62E+04 4.31E+02 2.16E+02 6.38E+00 
1.00E+02 1.12E-05 8.93E+04 4.47E+02 2.23E+02 6.61E+00 
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Table 33 
DOSE CALCULATION FOR INHALATION OF Pu-239 PARTICULATES PER Bq EXCRETED 
Pu-239 
AMAD - 1 micron 
Half Life - 2.20 E+04 Days 
ALI - 5 E+02 Bq 
Class - Y 
F u = 5.4 E-01 
Critical organ - red marrow 
Committed Dose Equivalent (EQ) (Red Marrow) = 7.6E-05 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Bone (Sv/Bq) Bone (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 1.68E-06 5.91E+05 1.18E+03 4.49E+01 5.38E+00 
2.00E-01 3.55E-06 2.81E+05 5.63E+02 2.14E+01 2.56E+00 
3.00E-01 5.32E-06 1.87E+05 3.75E+02 1.42E+01 1.71E+00 
4.00E-01 7.01E-06 1.42E+05 2.85E+02 1.08E+01 1.29E+00 
5.00E-01 8.61E-06 1.16E+05 2.32E+02 8.82E+00 1.05E-00 
6.00E-01 1.01E-05 9.90E+04 1.98E+02 7.52E+00 9.00E-01 
7.00E-01 1.16E-05 8.62E+04 1.72E+02 6.55E+00 7.84E-01 
8.00E-01 1.30E-05 7.69E+04 1.53E+02 5.84E+00 7.00E-01 
9.00E-01 1.43E-05 6.99E+04 1.39E+02 5.31E+00 6.36E-01 
1.00E+00 1.55E-05 1.55E-05 6.45E+04 1.29E+02 9.90E+00 5.87E-01 
2.00E+00 9.64E-06 1.03E+05 2.07E+02 7.88E+00 9.43E-01 
3.00E+00 6.09E-06 1.64E+05 3.28E+02 1.24E+01 1.49E+00 
4.00E+00 4.05E-06 2.46E+05 4.93E+02 1.87E+01 2.29E+00 
5.00E+00 2.87E-06 3.48E+05 6.96E+02 2.64E+01 3.17E+00 
6.00E+00 2.18E-06 4.58E+05 9.17E+02 3.48E+01 4.17E+00 
7.00E+00 1.78E-06 5.61E+05 1.12E+03 4.26E+01 5.11E+00 
8.00E+00 1.53E-06 6.53E+05 1.30E+03 4.96E+01 5.94E+00 
9.00E+00 1.38E-06 7.24E+05 1.44E+03 5.50E+01 6.59E+00 
1.00E+01 1.29E-06 7.75E+05 1.55E+03 5.89E+01 7.05E+00 
2.00E+01 1.00E-06 1.00E+06 2.00E+03 7.60E+01 9.10E+00 
3.00E+01 8.81E-07 1.13E+06 2.27E+03 8.62E+01 1.03E+01 
4.00E+01 8.04E-07 1.24E+06 2.48E+03 9.45E+01 1.13E+01 
5.00E+01 7.57E-07 1.32E+06 2.64E+03 1.00E+02 1.20E+01 
6.00E+01 7.28E-07 1.37E+06 2.74E+03 1.04E+02 1.25E+01 
7.00E+01 7.12E-07 1.40E+06 2.80E+03 1.06E+02 1.27E+01 
8.00E+01 7.03E-07 1.42E+06 2.84E+03 1.08E+02 1.29E+01 
9.00E+01 6.99E-07 1.43E+06 2.86E+03 1.08E+02 1.30E+01 
1.00E+01 6.99E-07 1.43E+06 2.86E+03 1.08E+02 1.30E+01 
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Table 34 
DOSE CALCULATION FOR INHALATION OF Am-241 PARTICULATES PER Bq EXCRETED 
Am-241 	 Half Life - 1.58 E+05 Days 
	
Class - W 




Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 2.5E-03 Sv/Bq 


























1.00E-01 1.49E-03 6.71E+02 3.35E-00 1.67E+00 5.10E-02 
2.00E-01 2.84E-03 3.52E+02 1.76E-00 8.80E-01 2.67E-02 
3.00E-01 3.87E-03 2.58E+02 1.29E-00 6.45E-01 1.96E-02 
4.00E-01 4.65E-03 2.15E+02 1.07E-00 5.37E-01 1.63E42 
5.00E-01 5.25E-03 1.90E+02 9.52E-01 4.76E-01 1.44E-02 
6.00E-01 5.70E-03 1.73E+02 8.68E-01 4.34E-01 1.31E-02 
7.00E-01 6.04E-03 1.65E+02 8.27E-01 4.13E-01 1.25E-02 
8.00E-01 6.30E-03 1.58E+02 7.93E-01 3.96E-01 1.20E-02 
9.00E-01 6.50E-03 1.53E+02 7.69E-01 3.84E-01 1.16E-02 
1.00E+00 6.66E-03 6.66E-03 1.50E+02 7.50E-01 3.75E-01 1.14E-02 
2.00E+00 4.93E-04 2.02E+03 1.01E+01 5.07E+00 1.54E-02 
3.00E+00 8.24E-05 1.21E+04 6.06E+01 3.03E+01 1.22E-01 
4.00E+00 5.49E-05 1.82E+04 9.10E+01 4.55E+01 1.38E+00 
5.00E+00 5.24E-05 1.90E+04 9.54E+01 4.77E+01 1.45E+00 
6.00E+00 5.17E-05 1.93E+04 9.67E+01 4.83E+01 1.47E+00 
7.00E+00 5.11E-05 1.95E+04 9.78E+01 4.89E+01 1.48E+00 
8.00E+00 5.06E-05 1.97E+04 9.88E+01 4.94E+01 1.50E+00 
9.00E+00 5.02E-05 1.99E+04 9.96E+01 4.98E+01 1.51E+00 
1.00E+01 4.97E-05 2.01E+04 1.00E+02 5.03E+01 1.52E+00 
2.00E+01 4.56E-05 2.19E+04 1.09E+02 5.48E+01 1.66E+00 
3.00E+01 4.17E-05 2.39E+04 1.19E+02 5.99E+01 1.82E+00 
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Table 35 
DOSE CALCULATION FOR INHALATION OF Am-242 PARTICULATES PER Bq EXCRETED 
Am-242 
	
Half Life - 6.68 E+01 Days 
	
Class - W 




Critical organ - bone 
Committed Dose Equivalent (EQ) (Bone) = 1.8E-07 Sv/Bq 


























1.00E-01 1.49E-03 6.71E+02 2.23E-04 1.20E-04 3.62E-06 
2.00E-01 2.84E-03 3.52E+02 1.17E-04 6.33E-05 1.90E-06 
3.00E-01 3.87E-03 2.58E+02 8.61E-05 4.65E-05 1.39E-06 
4.00E-01 .4.65E-03 2.15E+02 7.16E-05 3.87E-05 1.16E-06 
5.00E-01 5.25E-03 1.90E+02 6.34E-05 3.42E-05 1.02E-06 
6.00E-01 5.70E-03 1.75E+00 5.84E-05 3.15E-05 9.47E-07 
7.00E-01 6.04E-03 1.65E+00 5.51E-05 2.98E-05 8.94E-07 
8.00E-01 6.30E-03 1.58E+00 5.29E-05 2.85E-05 8.57E-07 
9.00E-01 6.50E-03 1.53E+02 5.12E-05 2.76E-05 8.30E-07 
1.00E+00 6.66E-03 6.66E-03 1.50E+03 5.00E-05 2.70E-05 8.10E-07 
2.00E+00 4.93E-04 2.02E+03 6.76E-04 3.65E-04 1.09E-05 
3.00E+00 8.24E-05 1.21E+04 4.04E-03 2.18E-03 6.55E-05 
4.00E+00 5.49E-05 1.82E+04 6.07E-03 3.27E-03 9.83E-05 
5.00E+00 5.24E-05 1.90E+04 6.36E-03 3.43E-03 1.03E-04 
6.00E+00 5.17E-05 1.93E+04 6.44E-03 3.48E-03 1.04E-04 
7.00E+00 5.11E-05 1.95E+04 6.52E-03 3.52E-03 1.05E-04 
8.00E+00 5.06E-05 1.97E+04 6.58E-03 3.55E-03 1.06E-04 
9.00E+00 5.02E-05 1.99E+04 6.64E-03 3.58E-03 1.07E-04 
1.00E+01 4.97E-05 2.01E+04 6.70E-03 3.62E-03 1.08E-04 
2.00E+01 4.56E-05 2.19E+04 7.30E-03 3.94E-03 1.18E-04 
3.00E+01 4.17E-05 2.39E+04 7.99E-03 4.31E-03 1.29E-04 
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Table 36 
DOSE CALCULATION FOR INHALATION OF Am-242m PARTICULATES PER Bq EXCRETED 
Am-242m 	 Half Life - 5.55 E+04 Days 
	
Class - W 




Critical organ - bone surface 
Committed Dose Equivalent (EQ) (Bone) = 2.5E-03 Sv/Bq 



















Dose Equiv. 	Dose Equiv. 
Bone (Sv/Bq) Bone (Sv/Bq) 
Excreted) 	Excreted) 
1.00E-01 1.49E-03 6.71E+02 3.35E-00 1.67E+00 5.10E-02 
2.00E-01 2.84E-03 3.52E+02 1.76E-00 8.80E-01 2.67E-02 
3.00E-01 3.87E-03 2.58E+02 1.29E-00 6.45E-01 1.96E-02 
4.00E-01 4.65E-03 2.15E+02 1.07E-00 5.37E-01 1.63E-02 
5.00E-01 5.25E-03 1.90E+02 9.52E-01 4.76E-01 1.44E-02 
6.00E-01 5.70E-03 1.73E+02 8.68E-01 4.34E-01 1.31E-02 
7.00E-01 6.04E-03 1.65E+02 8.27E-01 4.13E-01 1.25E-02 
8.00E-01 6.30E-03 1.58E+02 7.93E-01 3.96E-01 1.20E-02 
9.00E-01 6.50E-03 1.53E+02 7.69E-01 3.84E-01 1.16E-02 
1.00E+00 6.66E-03 6.66E-03 1.50E+02 7.50E-01 3.75E-01 1.14E-02 
2.00E+00 4.93E-04 2.02E+03 1.01E+01 5.07E+00 1.54E-02 
3.00E+00 8.24E-05 1.21E+04 6.06E+01 3.03E+01 1.22E-01 
4.00E+00 5.49E-05 1.82E+04 9.10E+01 4.55E+01 1.38E+00 
5.00E+00 5.24E-05 1.90E+04 9.54E+01 4.77E+01 1.45E+00 
6.00E+00 5.17E-05 1.93E+04 9.67E+01 4.83E+01 1.47E+00 
7.00E+00 5.11E-05 1.95E+04 9.78E+01 4.89E+01 1.48E+00 
8.00E+00 5.06E-05 1.97E+04 9.88E+01 4.94E+01 1.50E+00 
9.00E+00 5.02E-05 1.99E+04 9.96E+01 4.98E+01 1.51E+00 
1.00E+01 4.97E-05 2.01E+04 1.00E+02 5.03E+01 1.52E+00 
2.00E+01 4.56E-05 2.19E+04 1.09E+02 5.48E+01 1.66E+00 




FLOW CHART  
1 	 Enter ALI (Bq), committed dose eq. (Sv/Bq), 
Wt. committed dose eq. (Sv/Bq) 
	► Fraction of intake in urine (This information should come 
from previously entered data file.) 
1 
Intake = 





ALI (from 1) 
Fraction of ALI - 
Committed dose eq. = Intake * committed dose eq. 
(Bq * Sv/Bq = Sv) (from 1) 
Wt. com. dose eq. = Intake * wt. com. dose eq. 
(Bq * Sv/Bq = Sv) (from 1) 
PRINT 
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